https://lifesciencesbc.ca/news/all-news/ 2026-04-13T23:42:06+00:00 https://lifesciencesbc.ca/ecosystem/20497/ 2021-03-06T17:52:06+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-to-present-at-h-c-wainwright-global-life-sciences-conference/ 2021-03-06T18:05:21+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/neoleukin-logo-stacked-fullcolor-square-rgb-300x300.jpg https://lifesciencesbc.ca/members/regulations-amending-the-patented-medicines-regulations-pmprb/ 2021-03-06T18:07:16+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-submission-of-investigational-new-drug-application-for-nl-201-de-novo-protein-immunotherapy-candidate-for-cancer/ 2021-03-06T18:07:35+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-participation-in-piper-sandler-32nd-annual-virtual-healthcare-conference/ 2021-03-06T18:08:24+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/neoleukin-logo-stacked-fullcolor-square-rgb-150x150.jpg https://lifesciencesbc.ca/members/an-interview-with-business-in-vancouver-how-covid-19-is-challenging-the-life-sciences-sector/ 2021-03-06T18:08:30+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-to-present-at-the-stifel-2020-virtual-healthcare-conference/ 2021-03-06T18:08:31+00:00 https://lifesciencesbc.ca/members/exciting-new-developments-at-farmers-hive-new-educational-features-and-interesting-plant-research-projects-happening/ 2021-03-06T18:08:33+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/11/farmers-hive-150x150.png https://lifesciencesbc.ca/members/neoleukin-therapeutics-presents-preclinical-combination-data-for-nl-201-at-society-for-immunotherapy-of-cancers-35th-anniversary-annual-meeting-sitc-2020/ 2021-03-06T18:08:33+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/neoleukin-logo-stacked-fullcolor-square-rgb-150x150.jpg https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-third-quarter-2020-financial-results-and-corporate-update/ 2021-03-06T18:08:35+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/neoleukin-logo-stacked-fullcolor-square-rgb-150x150.jpg https://lifesciencesbc.ca/members/curevacs-positive-preliminary-results-for-a-covid-19-vaccine-showcases-important-canadian-connection/ 2021-03-06T18:08:38+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-publication-in-science-of-de-novo-protein-decoys-that-block-covid-19-infection-in-vitro-and-protect-animals-in-vivo/ 2021-03-06T18:08:40+00:00 https://lifesciencesbc.ca/members/5th-lifesciences-bc-investor-summit-attracts-international-interest/ 2021-03-06T18:08:43+00:00 https://lifesciencesbc.ca/members/east-west-academic-industry-research-collaboration-to-identify-lung-cancer-biomarkers/ 2021-03-06T18:08:44+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-appoints-holly-k-vance-as-general-counsel/ 2021-03-06T18:09:18+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-abstract-accepted-for-presentation-at-the-society-for-immunotherapy-of-cancers-35th-anniversary-annual-meeting-sitc-2020/ 2021-03-06T18:09:19+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/neoleukin-logo-stacked-fullcolor-square-rgb-150x150.jpg https://lifesciencesbc.ca/members/lifesciences-bc-recognizes-annual-award-winners/ 2021-03-06T18:09:31+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/02/LSBC-logo-for-job-board2-300x113.jpg https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-appointment-of-martin-babler-to-board-of-directors/ 2021-03-06T18:09:32+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-to-present-at-h-c-wainwright-22nd-annual-global-investment-conference/ 2021-03-06T18:09:33+00:00 https://lifesciencesbc.ca/members/join-us-at-the-2020-lifesciences-bc-annual-award-winners-recognition-event/ 2021-03-06T18:09:34+00:00 https://lifesciencesbc.ca/members/delmar-announces-19-6-million-private-placement-priced-at-the-market/ 2021-03-06T18:09:37+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/DelMar_Logo-scaled.jpg https://lifesciencesbc.ca/members/delmar-announces-approval-of-merger-by-stockholders/ 2021-03-06T18:10:13+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/DelMar_Logo-scaled.jpg https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-second-quarter-2020-financial-results-provides-corporate-update/ 2021-03-06T18:10:14+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/neoleukin-logo-stacked-fullcolor-square-rgb.jpg https://lifesciencesbc.ca/members/arbutus-reports-second-quarter-2020-financial-results-and-provides-corporate-update/ 2021-03-06T18:10:16+00:00 https://lifesciencesbc.ca/wp-content/uploads/2016/06/Arbutus.png https://lifesciencesbc.ca/members/government-of-canada-announces-major-steps-in-treating-and-preventing-covid-19-through-vaccines-and-therapies/ 2021-03-06T18:10:20+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-to-present-at-canaccord-genuity-40th-annual-growth-conference/ 2021-03-06T18:10:20+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-to-host-second-quarter-2020-financial-results-corporate-update-conference-call-and-webcast-on-august-12-2020/ 2021-03-06T18:10:21+00:00 https://lifesciencesbc.ca/members/arbutus-to-present-at-wedbush-pacgrow-healthcare-virtual-conference/ 2021-03-06T18:10:21+00:00 https://lifesciencesbc.ca/members/ico-therapeutics-inc-announces-publication-of-oral-amphotericin-b-ico-019-phase-1-safety-study-results-in-prestigious-infectious-diseases-journal/ 2021-03-06T18:10:22+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/07/ICO-THERAPEUTICS-300x200.png https://lifesciencesbc.ca/members/baxter-and-ayogo-announce-partnership-for-unique-digital-health-solutions-for-home-dialysis/ 2021-03-06T18:10:23+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/07/Ayogo-Logo-.png https://lifesciencesbc.ca/members/arbutus-to-report-second-quarter-2020-financial-results/ 2021-03-06T18:10:24+00:00 https://lifesciencesbc.ca/wp-content/uploads/2016/06/Arbutus.png https://lifesciencesbc.ca/members/ico-therapeutics-inc-announces-oral-amphotericin-b-ico-019-results-to-be-presented-at-prestigious-american-pharmaceutical-sciences-meeting-and-discussion-updates/ 2021-03-06T18:10:25+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/07/ICO-THERAPEUTICS-300x200.png https://lifesciencesbc.ca/members/delmar-pharmaceuticals-to-host-conference-call-to-discuss-proposed-acquisition-of-adgero-pharmaceuticals/ 2021-03-06T18:10:27+00:00 https://lifesciencesbc.ca/members/korea-virtual-trade-mission-asia-procurement-opportunities/ 2021-03-06T18:10:28+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/07/canada-flag-150x150.png https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-proposed-public-offering/ 2021-03-06T18:10:32+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-pricing-of-76-2-million-public-offering/ 2021-03-06T18:10:32+00:00 https://lifesciencesbc.ca/members/call-to-action-covid-19-all-bc-medical-suppliers-laboratories-and-service-providers-3/ 2021-03-06T18:10:35+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-receives-500000-loan-from-the-national-brain-tumor-society-and-national-foundation-for-cancer-research-to-support-val-083s-participation-in-a-pivotal-study-for-glioblastoma/ 2021-03-06T18:10:36+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-presents-positive-interim-data-on-val-083-demonstrating-favorable-outcomes-in-both-newly-diagnosed-and-recurrent-gbm-at-the-aacr-virtual-annual-meeting-ii/ 2021-03-06T18:12:36+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-presents-preclinical-data-for-nl-201-and-de-novo-protein-design-technology-at-american-association-for-cancer-research-aacr-virtual-annual-meeting-ii/ 2021-03-06T18:12:37+00:00 https://lifesciencesbc.ca/members/first-patient-dosed-with-a9t-1101-first-product-candidate-in-alpha-9-theranostics-pipeline-initiates-clinical-testing/ 2021-03-06T18:12:40+00:00 https://lifesciencesbc.ca/members/delmar-to-acquire-adgero-biopharmaceuticals-expands-late-stage-oncology-pipeline/ 2021-03-06T18:12:41+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-to-host-investor-rd-showcase-highlighting-de-novo-protein-therapeutics/ 2021-03-06T18:12:41+00:00 https://lifesciencesbc.ca/members/csl-behring-to-acquire-biotech-company-vitaeris/ 2021-03-06T18:12:42+00:00 https://lifesciencesbc.ca/members/find-therapeutics-a-new-drug-development-company-dedicated-to-breakthrough-therapies-against-rare-diseases-launches-in-montreal/ 2021-03-06T18:12:44+00:00 https://lifesciencesbc.ca/members/global-coalition-for-adaptive-research-gcar-selects-delmar-pharmaceuticals-val-083-to-participate-in-the-gbm-agile-pivotal-study-an-adaptive-clinical-trial-platform-in-glioblastoma-multiforme/ 2021-03-06T18:12:45+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-appointment-of-erin-lavelle-to-board-of-directors/ 2021-03-06T18:12:48+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-to-present-updates-of-two-phase-2-clinical-trials-of-val-083-at-the-2020-american-association-for-cancer-research-virtual-annual-meeting-ii/ 2021-03-06T18:12:48+00:00 https://lifesciencesbc.ca/members/arbutus-to-present-at-jefferies-virtual-healthcare-conference/ 2021-03-06T18:12:51+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-to-present-at-jefferies-virtual-healthcare-conference/ 2021-03-06T18:12:51+00:00 https://lifesciencesbc.ca/members/happy-clinical-trials-day/ 2021-03-06T18:12:58+00:00 https://lifesciencesbc.ca/members/arbutus-announces-single-dose-week-12-data-in-chronic-hepatitis-b-subjects-with-60-mg-ab-729-demonstrating-a-significant-and-continuous-reduction-in-hbsag/ 2021-03-06T18:13:00+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-multiple-presentations-at-american-association-for-cancer-research-aacr-virtual-annual-meeting-ii/ 2021-03-06T18:13:02+00:00 https://lifesciencesbc.ca/members/industrial-assistance-program-iap-support-government-making-available-through-nrc-irap/ 2021-03-06T18:13:03+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-announces-fiscal-third-quarter-2020-financial-results-and-recent-corporate-updates/ 2021-03-06T18:13:04+00:00 https://lifesciencesbc.ca/members/nrc-irap-eureka-call-for-proposal-by-may-15-2020/ 2021-03-06T18:13:05+00:00 https://lifesciencesbc.ca/members/arbutus-reports-first-quarter-2020-financial-results-provides-pipeline-update-and-announces-new-research-initiative-to-identify-novel-antiviral-therapies-for-the-treatment-of-coronavirus-infections/ 2021-03-06T18:13:06+00:00 https://lifesciencesbc.ca/members/arbutus-to-present-at-ubs-virtual-global-healthcare-conference/ 2021-03-06T18:13:06+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-first-quarter-2020-financial-results-and-provides-business-update/ 2021-03-06T18:13:41+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-to-present-at-virtual-bofa-securities-2020-health-care-conference/ 2021-03-06T18:13:41+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-nasdaqdmpi-provides-enrollment-update-in-phase-2-clinical-trial-of-val-083-for-adjuvant-treatment-of-brain-tumors/ 2021-03-06T18:13:42+00:00 https://lifesciencesbc.ca/members/arbutus-to-report-first-quarter-2020-financial-results/ 2021-03-06T18:13:43+00:00 https://lifesciencesbc.ca/members/free-covid-19-health-tracking-app-launched-to-help-canadians-track-and-manage-their-health-and-provide-frontline-researchers-and-public-health-officials-real-time-large-scale-open-source-public-data/ 2021-03-06T18:13:44+00:00 https://lifesciencesbc.ca/members/canada-safe-food-consortium-gears-up-to-feed-vulnerable-canadians-and-frontline-covid/ 2021-03-06T18:13:45+00:00 https://lifesciencesbc.ca/members/get-10000-a-year-to-hire-students-through-the-innovator-skills-initiative-isi-grant-program/ 2021-03-06T18:13:46+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-change-of-location-of-annual-meeting-of-stockholders-to-be-held-may-5-2020/ 2021-03-06T18:13:48+00:00 https://lifesciencesbc.ca/members/covid-19-open-innovation-challenge/ 2021-03-06T18:13:55+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/09/Hoffman-La-Roche-Logo-300x156.png https://lifesciencesbc.ca/members/2020-canada-gairdner-awards-recognize-world-renowned-scientists-for-transformative-contributions-to-research-that-impact-human-health/ 2021-03-06T18:13:59+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-receives-nasdaq-bid-price-extension/ 2021-03-06T18:14:03+00:00 https://lifesciencesbc.ca/members/covid-19-resources-and-support-for-canadian-businesses/ 2021-03-06T18:14:04+00:00 https://lifesciencesbc.ca/members/covid-19-information-for-employers-and-employees-federal-and-provincial-source-information/ 2021-03-06T18:14:05+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/03/BC.png https://lifesciencesbc.ca/wp-content/uploads/2020/03/CANADA-300x150.png https://lifesciencesbc.ca/members/applications-now-open-for-the-2020-new-ventures-bc-competition-presented-by-innovate-bc/ 2021-03-06T18:14:07+00:00 https://lifesciencesbc.ca/members/statement-on-canadas-drug-supply/ 2021-03-06T18:14:07+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-year-end-financial-results/ 2021-03-06T18:14:08+00:00 https://lifesciencesbc.ca/members/arbutus-reports-fourth-quarter-and-year-end-2019-financial-results-confirms-2020-corporate-objectives-and-provides-pipeline-update/ 2021-03-06T18:14:09+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-nasdaqdmpi-reports-over-50-enrollment-in-phase-2-clinical-trial-of-val-083-for-adjuvant-treatment-of-brain-tumors/ 2021-03-06T18:14:11+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-to-host-2019-financial-results-conference-call-and-webcast-on-march-12-2020/ 2021-03-06T18:14:11+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-appointment-of-robert-k-ho-as-chief-financial-officer/ 2021-03-06T18:14:12+00:00 https://lifesciencesbc.ca/members/arbutus-to-report-fourth-quarter-and-year-end-2019-financial-results/ 2021-03-06T18:14:12+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-to-present-at-cowen-and-company-40th-annual-health-care-conference/ 2021-03-06T18:14:39+00:00 https://lifesciencesbc.ca/members/enclear-therapies-announces-10m-series-a-financing/ 2021-03-06T18:14:40+00:00 https://lifesciencesbc.ca/members/emerald-health-pharmaceuticals-to-present-at-2020-actrims-conference-on-multiple-sclerosis/ 2021-03-06T18:14:40+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-nasdaqdmpi-enrolls-final-patient-in-phase-2-clinical-trial-of-val-083-for-first-line-treatment-of-brain-tumors/ 2021-03-06T18:14:41+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-announces-fiscal-second-quarter-2020-financial-results-and-recent-corporate-updates/ 2021-03-06T18:14:42+00:00 https://lifesciencesbc.ca/members/arbutus-announces-decision-to-discontinue-ab-452-and-to-pursue-development-of-a-next-generation-hbv-specific-oral-rna-destabilizer/ 2021-03-06T18:14:43+00:00 https://lifesciencesbc.ca/members/precision-medicine-being-advanced-through-data-privacy-and-security/ 2021-03-06T18:14:44+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-to-participate-in-guggenheim-healthcare-talks-idea-forum-oncology-day/ 2021-03-06T18:14:44+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-to-attend-the-22nd-annual-bio-ceo-investor-conference-in-new-york-city-february-10-and-11-2020/ 2021-03-06T18:14:45+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-announces-peer-reviewed-publication-of-interim-results-of-phase-2-clinical-trial-of-val-083-as-first-line-treatment-in-newly-diagnosed-mgmt-unmethylated-glioblastoma-multiforme/ 2021-03-06T18:14:45+00:00 https://lifesciencesbc.ca/members/shimadzu-medical-systems-usa-and-nz-technologies-sign-agreement-to-bring-tipso-airpad-technology-to-the-ixr-suite/ 2021-03-06T18:14:51+00:00 https://lifesciencesbc.ca/members/generator-10-0-call-for-applications-deadline-feb-7th-2020/ 2021-03-06T18:14:55+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-closing-of-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares/ 2021-03-06T18:14:55+00:00 https://lifesciencesbc.ca/members/wat-medical-will-attend-2020-ces-to-exhibit-their-innovative-wearable-technologies-emeterm-the-anti-vomiting-wrist-band-and-headaterm-the-anti-migraine-head-patch/ 2021-03-06T18:14:55+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-pricing-of-75-0-million-public-offering/ 2021-03-06T18:14:56+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-proposed-public-offering-of-common-stock/ 2021-03-06T18:14:56+00:00 https://lifesciencesbc.ca/members/dr-stirling-bryan-announced-as-bc-ahsn-president-as-of-january-2020/ 2021-03-06T18:14:59+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-scientific-advisory-board/ 2021-03-06T18:15:00+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-to-present-at-the-ld-micro-12th-annual-main-event-on-december-10-2019/ 2021-03-06T18:15:04+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-to-present-at-piper-jaffray-31st-annual-healthcare-conference/ 2021-03-06T18:15:07+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-presents-positive-interim-data-of-val-083-demonstrating-favorable-outcomes-in-both-recurrent-and-newly-diagnosed-gbm/ 2021-03-06T18:16:20+00:00 https://lifesciencesbc.ca/members/phoenix-molecular-designs-initiates-its-phase-1-1b-program-to-evaluate-pmd-026-in-patients-with-resistant-forms-of-advanced-breast-cancer/ 2021-03-06T18:16:21+00:00 https://lifesciencesbc.ca/members/phoenix-molecular-designs-announces-12-million-in-seed-financing/ 2021-03-06T18:16:22+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-announces-fiscal-first-quarter-2020-financial-results-and-recent-corporate-updates/ 2021-03-06T18:16:25+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-corporate-update-and-third-quarter-2019-financial-results/ 2021-03-06T18:16:27+00:00 https://lifesciencesbc.ca/members/dynacare-launches-jointstat-testing-in-canada/ 2021-03-06T18:16:33+00:00 https://lifesciencesbc.ca/members/back-arbutus-reports-third-quarter-2019-financial-results-and-provides-corporate-update/ 2021-03-06T18:16:35+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-to-host-key-opinion-leader-summit-on-glioblastoma-multiforme-and-the-potential-for-treatment-with-val-083/ 2021-03-06T18:16:42+00:00 https://lifesciencesbc.ca/members/dr-michael-hayden-joins-abcelleras-board-of-directors/ 2021-03-06T18:16:43+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-to-present-updates-of-two-phase-2-clinical-trials-of-val-083-at-the-2019-society-for-neurooncology-annual-meeting/ 2021-03-06T18:16:44+00:00 https://lifesciencesbc.ca/members/arbutus-to-report-third-quarter-2019-financial-results/ 2021-03-06T18:16:44+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-to-present-on-october-29th-at-the-5th-annual-dawson-james-small-cap-growth-conference/ 2021-03-06T18:16:45+00:00 https://lifesciencesbc.ca/members/arbutus-announces-decision-to-discontinue-development-of-ab-506-an-oral-capsid-inhibitor-for-the-treatment-of-chronic-hepatitis-b/ 2021-03-06T18:16:46+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-to-present-at-the-inaugural-microcap-rodeo-investor-conference-on-october-15-2019-at-1130-am-central-time/ 2021-03-06T18:16:46+00:00 https://lifesciencesbc.ca/members/phoenix-molecular-designs-receives-fda-clearance-to-begin-phase-1-1b-clinical-trial-with-pmd-026-a-first-in-class-rsk-inhibitor-targeting-advanced-breast-cancer/ 2021-03-06T18:16:47+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-additions-to-management-team/ 2021-03-06T18:16:48+00:00 https://lifesciencesbc.ca/members/arbutus-to-participate-in-upcoming-investor-conferences-6/ 2021-03-06T18:16:48+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-announces-fiscal-year-2019-financial-results-and-recent-corporate-updates/ 2021-03-06T18:16:50+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-to-present-at-the-fall-investor-summit-on-september-16-2019/ 2021-03-06T18:16:50+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4/ 2021-03-06T18:16:52+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-reports-full-compliance-with-nasdaq-listing-criteria/ 2021-03-06T18:16:52+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-relocates-headquarters-to-san-diego-california/ 2021-03-06T18:16:53+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-anticipates-current-cash-runway-will-provide-sufficient-capital-for-full-enrollment-in-all-three-patient-groups-in-two-phase-2-clinical-trials/ 2021-03-06T18:16:54+00:00 https://lifesciencesbc.ca/members/arbutus-biopharma-appoints-andrew-cheng-m-d-ph-d-to-its-board-of-directors/ 2021-03-06T18:16:55+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-reports-updated-results-on-twenty-patients-from-the-phase-2-clinical-trial-of-val-083-as-first-line-treatment-in-newly-diagnosed-mgmt-unmethylated-glioblastoma-multiforme-gbm/ 2021-03-06T18:16:56+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-announces-pricing-of-6-8-million-underwritten-public-offering/ 2021-03-06T18:16:56+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-and-aquinox-pharmaceuticals-complete-merger-transaction/ 2021-03-06T18:16:58+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-to-present-at-canaccord-genuity-39th-annual-growth-conference/ 2021-03-06T18:16:58+00:00 https://lifesciencesbc.ca/members/aquinox-pharmaceuticals-and-neoleukin-therapeutics-announce-merger-agreement/ 2021-03-06T18:17:00+00:00 https://lifesciencesbc.ca/members/new-form-10-q-for-aquinox-pharmaceuticals-inc/ 2021-03-06T18:17:36+00:00 https://lifesciencesbc.ca/members/arbutus-to-participate-at-wedbush-pacgrow-healthcare-conference/ 2021-03-06T18:17:36+00:00 https://lifesciencesbc.ca/members/arbutus-to-report-second-quarter-2019-financial-results/ 2021-03-06T18:17:37+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-achieves-two-thirds-enrollment-for-phase-2-clinical-trial-of-val-083-as-first-line-treatment-in-newly-diagnosed-mgmt-unmethylated-glioblastoma-multiforme-gbm/ 2021-03-06T18:17:38+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-enrolls-first-patient-in-the-recently-approved-adjuvant-setting-arm-of-phase-2-study-of-val-083-for-the-treatment-of-mgmt-unmethylated-glioblastoma-multiforme/ 2021-03-06T18:17:39+00:00 https://lifesciencesbc.ca/members/delmar-announces-relocation-of-company-headquarters-to-san-diego/ 2021-03-06T18:17:41+00:00 https://lifesciencesbc.ca/members/arbutus-announces-preliminary-phase-1a-1b-clinical-trial-results-for-ab-506-an-oral-capsid-inhibitor-in-development-for-people-with-chronic-hepatitis-b/ 2021-03-06T18:17:41+00:00 https://lifesciencesbc.ca/members/arbutus-sells-part-of-its-onpattro-patisiran-royalty-interest-to-omers/ 2021-03-06T18:17:42+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-announces-extension-of-rights-offering-to-july-12-2019/ 2021-03-06T18:17:43+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-announces-termination-of-rights-offering/ 2021-03-06T18:17:43+00:00 https://lifesciencesbc.ca/members/arbutus-receives-regulatory-clearance-to-initiate-phase-1a-1b-clinical-trial-of-ab-7/ 2021-03-06T18:17:44+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/06/arbutus-Biopharma-150x63.jpg https://lifesciencesbc.ca/members/scn-launches-funding-competition-to-support-translational-stem-cell-research-across-canada/ 2021-03-06T18:17:44+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/06/Stem-cell-network-300x150.png https://lifesciencesbc.ca/members/delmar-pharmaceuticals-updates-the-terms-of-previously-announced-rights-offering/ 2021-03-06T18:17:45+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/05/delmar-logo-500-300x85.jpg https://lifesciencesbc.ca/members/arbutus-to-participate-at-jmp-securities-life-sciences-conference/ 2021-03-06T18:17:45+00:00 https://lifesciencesbc.ca/members/arbutus-to-participate-at-jmp-securities-life-sciences-conference-2/ 2021-03-06T18:17:45+00:00 https://lifesciencesbc.ca/wp-content/uploads/2016/06/Arbutus.png https://lifesciencesbc.ca/members/delmar-provides-clinical-update-on-val-083-from-ongoing-first-and-second-line-trials-in-patients-with-mgmt-unmethylated-glioblastoma-at-a-key-opinion-leader-forum-during-the-american-society-of-clini/ 2021-03-06T18:17:47+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/05/delmar-logo-500-300x85.jpg https://lifesciencesbc.ca/members/delmar-pharmaceuticals-announces-3-6-million-registered-direct-offering/ 2021-03-06T18:17:49+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/05/delmar-logo-500-300x85.jpg https://lifesciencesbc.ca/wp-content/uploads/2019/05/delmar-logo-500.jpg https://lifesciencesbc.ca/members/emeterm-and-headaterm-are-approved-by-tga-australia/ 2021-03-06T18:17:50+00:00 https://lifesciencesbc.ca/wp-content/uploads/2017/07/wat-medical-300x87-300x87.jpg https://lifesciencesbc.ca/members/delmar-pharmaceuticals-updates-key-dates-of-rights-offering/ 2021-03-06T18:17:50+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/05/delmar-logo-500-300x85.jpg https://lifesciencesbc.ca/members/delmar-pharmaceuticals-announces-expansion-of-scientific-advisory-board/ 2021-03-06T18:17:51+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-announces-third-quarter-fiscal-year-2019-financial-results/ 2021-03-06T18:17:52+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-announces-key-dates-and-timeline-for-stockholder-participation-in-rights-offering/ 2021-03-06T18:17:53+00:00 https://lifesciencesbc.ca/members/arbutus-to-present-at-upcoming-may-2019-conferences/ 2021-03-06T18:17:53+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-announces-1-for-10-reverse-stock-split/ 2021-03-06T18:17:54+00:00 https://lifesciencesbc.ca/members/arbutus-reports-first-quarter-2019-financial-results-and-provides-corporate-update/ 2021-03-06T18:17:55+00:00 https://lifesciencesbc.ca/members/delmar-presents-data-supporting-val-083-as-potential-treatment-for-pediatric-brain-tumors-at-sno-pediatric-neuro-oncology-conference/ 2021-03-06T18:17:56+00:00 https://lifesciencesbc.ca/members/arbutus-to-report-first-quarter-2019-financial-results/ 2021-03-06T18:17:56+00:00 https://lifesciencesbc.ca/members/first-ai-enabled-roi-radiation-reduction-shutter-technology-fluoroshield-cleared-by-fda/ 2021-03-06T18:17:57+00:00 https://lifesciencesbc.ca/members/wat-medical-returns-cruise-show-with-us-partner-vikand/ 2021-03-06T18:17:57+00:00 https://lifesciencesbc.ca/members/pharmaust-successfully-reformulates-cancer-drug/ 2021-03-06T18:17:58+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-welcomes-dr-john-de-groot-chairman-ad-interim-of-the-department-of-neuro-oncology-at-md-anderson-cancer-center-as-founding-member-of-the-companys-scientific-advisory-board/ 2021-03-06T18:17:58+00:00 https://lifesciencesbc.ca/members/genxys-health-care-systems-announces-completion-of-oversubscribed-seed-round-financing-to-launch-leading-precision-prescribing-software-into-the-us-market-2/ 2021-03-06T18:17:59+00:00 https://lifesciencesbc.ca/members/natalie-dakers-receives-2019-milton-wong-award-for-leadership/ 2021-03-06T18:18:00+00:00 https://lifesciencesbc.ca/members/cdrd-and-triumf-announce-collaboration-to-revolutionize-the-fight-against-cancer-with-targeted-alpha-therapy/ 2021-03-06T18:18:00+00:00 https://lifesciencesbc.ca/members/evening-of-inspiration-and-enlightenment-for-women-in-health-sciences/ 2021-03-06T18:18:30+00:00 https://lifesciencesbc.ca/members/arbutus-reports-fourth-quarter-and-year-end-2018-financial-results-and-describes-recent-clinical-accomplishments-and-key-2019-objectives/ 2021-03-06T18:18:31+00:00 https://lifesciencesbc.ca/members/behind-the-seizure-program-expansion-helps-speed-the-diagnosis-of-genetic-epilepsy-in-younger-children-experiencing-unprovoked-seizures/ 2021-03-06T18:18:34+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-announces-second-quarter-fiscal-year-2019-financial-results/ 2021-03-06T18:18:39+00:00 https://lifesciencesbc.ca/members/cdrd-invests-in-sitka-biopharma-to-advance-bladder-cancer-treatment-to-clinical-trial/ 2021-03-06T18:18:41+00:00 https://lifesciencesbc.ca/members/essa-pharma-presents-favorable-initial-phase-1-clinical-pharmacology-data-of-epi-7386-for-advanced-forms-of-prostate-cancer-at-the-2021-asco-genitourinary-cancers-symposium/ 2021-03-12T23:05:45+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/09/Essa-Pharma-logo-300x158.jpg https://lifesciencesbc.ca/members/abcellera-appoints-ester-falconer-ph-d-as-chief-technology-officer/ 2021-03-12T23:06:20+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/11/AbCellera_700x350_Accelevents-1-e1610658038365-300x157.png https://lifesciencesbc.ca/members/nominations-are-open-for-the-2021-dr-paul-janssen-award/ 2021-03-12T23:57:40+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/02/janssen_consumer-logo-2_b-1-300x231.jpg https://lifesciencesbc.ca/members/qu-biologics-receives-funding-for-covid-19-prevention-treatment-research-with-qus-novel-immunotherapy-platform/ 2021-03-13T00:13:51+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/12/Qu-Biologics_logo.png https://lifesciencesbc.ca/members/aurinia-announces-collaboration-and-licensing-agreement-with-otsuka-pharmaceutical-co-ltd-for-the-development-and-commercialization-of-voclosporin-in-europe-and-japan/ 2021-03-13T00:14:44+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/Aurinia-logo-web-700px-e1597948106593.png https://lifesciencesbc.ca/members/aurinia-and-lonza-announce-exclusive-agreement-for-dedicated-voclosporin-manufacturing-capacity/ 2021-03-13T00:18:34+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/10/Aurinia-Pharmaceuticals-300x117.png https://lifesciencesbc.ca/members/zanidatamab-clinical-data-selected-for-oral-presentation-at-the-american-society-of-clinical-oncology-asco-gastrointestinal-cancers-symposium/ 2021-03-13T00:20:10+00:00 https://lifesciencesbc.ca/wp-content/uploads/2016/05/558px-Zymeworks_Logo.svg-300x135.png https://lifesciencesbc.ca/members/chinook-therapeutics-announces-license-agreement-with-morehouse-school-of-medicine-for-development-of-therapies-in-kidney-diseases-disproportionately-affecting-african-americans-and-underserved-commun/ 2021-03-13T00:22:57+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/12/logo-300x61.png https://lifesciencesbc.ca/members/qu-biologics-completes-8m-financing/ 2021-03-13T00:24:02+00:00 https://lifesciencesbc.ca/wp-content/uploads/2016/06/Qu_Biologics.png https://lifesciencesbc.ca/members/zymeworks-announces-expansion-of-zanidatamab-pivotal-trial-in-her2-amplified-biliary-tract-cancer-in-asia-in-collaboration-with-beigene/ 2021-03-13T00:25:54+00:00 https://lifesciencesbc.ca/wp-content/uploads/2016/05/558px-Zymeworks_Logo.svg-300x135.png https://lifesciencesbc.ca/members/lifelabs-partners-with-thrive-health-to-make-it-easier-and-safer-for-canadians-to-confidently-return-to-work-during-the-covid-19-pandemic/ 2021-03-13T00:29:36+00:00 https://lifesciencesbc.ca/wp-content/uploads/2017/11/LifeLabs_logo_rgb_300dpi-300x80.jpg https://lifesciencesbc.ca/members/zymeworks-receives-fda-breakthrough-therapy-designation-for-her2-targeted-bispecific-antibody-zanidatamab-in-patients-with-biliary-tract-cancer/ 2021-03-13T00:30:01+00:00 https://lifesciencesbc.ca/wp-content/uploads/2016/05/558px-Zymeworks_Logo.svg-300x135.png https://lifesciencesbc.ca/members/livanova-and-gyrus-capital-enter-into-agreement-for-the-purchase-of-heart-valve-business/ 2021-03-13T00:30:29+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/03/LIVANOVA-LOGO-150x150.png https://lifesciencesbc.ca/members/inmed-licenses-midrops-delivery-technology-from-eyecro-for-the-delivery-of-therapeutic-cannabinoids/ 2021-03-13T00:36:28+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/aurinia-pharmaceuticals-to-present-at-the-piper-sandler-32nd-annual-virtual-healthcare-conference/ 2021-03-13T00:37:22+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/Aurinia-logo-web-700px-300x117.png https://lifesciencesbc.ca/members/bc-tech-innovation-hub-announcement/ 2021-03-13T00:38:11+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/03/BC_Tech_Association-300x101.png https://lifesciencesbc.ca/members/meet-the-praxis-sci-incubate-2020-cohort/ 2021-03-13T00:38:45+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/10/Praxis_logo_142_37.png https://lifesciencesbc.ca/members/inmed-announces-results-of-initial-phase-1-clinical-trial-of-inm-755-cbn-cream-in-healthy-subjects/ 2021-03-13T00:39:37+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/inmed-announces-election-of-directors-2/ 2021-03-13T00:40:04+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/symvivo-corporation-announces-research-collaboration-with-janssen/ 2021-03-13T00:41:09+00:00 https://lifesciencesbc.ca/members/abcellera-expands-technology-stack-with-acquisition-of-trianni-for-90-million/ 2021-03-13T00:41:23+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/05/AbCellera_Full-Colour_CMYK_2-1-300x212.jpg https://lifesciencesbc.ca/members/abcellera-and-invetx-expand-multi-year-antibody-discovery-collaboration-in-animal-health/ 2021-03-13T00:41:57+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/05/AbCellera_Full-Colour_CMYK_2-1-300x212.jpg https://lifesciencesbc.ca/members/peter-thiel-joins-abcelleras-board-of-directors/ 2021-03-13T00:42:39+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/05/AbCellera-Logo-White-Background-150x150.png https://lifesciencesbc.ca/members/abcellera-discovered-antibody-granted-interim-authorization-by-health-canada-as-a-treatment-for-covid-19/ 2021-03-13T00:42:52+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/AbCellera_Full-Colour_RGB_2-1-300x212.png https://lifesciencesbc.ca/members/aurinia-announces-new-employment-inducement-grant-under-nasdaq-listing-rule-5635c4/ 2021-03-13T00:43:42+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/Aurinia-logo-300x92.jpg https://lifesciencesbc.ca/members/pharmaceuticals-and-baymedica-announce-collaboration-for-manufacturing-and-testing-of-novel-cannabinoid-therapeutics/ 2021-03-13T00:45:43+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/zymeworks-and-alx-oncology-announce-clinical-collaboration-evaluating-zanidatamab-with-the-cd47-blocker-alx148-in-patients-with-advanced-her2%e2%80%91expressing-breast-cancer/ 2021-03-13T00:59:20+00:00 https://lifesciencesbc.ca/wp-content/uploads/2016/05/558px-Zymeworks_Logo.svg-300x135.png https://lifesciencesbc.ca/members/inmed-pharmaceuticals-announces-the-closing-of-us8-million-public-offering/ 2021-03-13T01:01:06+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/21032/ 2021-03-13T01:04:36+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/aurinia-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference/ 2021-03-13T01:16:39+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/Aurinia-logo-300x92.jpg https://lifesciencesbc.ca/members/a-global-health-crisis-is-not-the-time-to-limit-access-to-life-saving-vaccines-and-medicines/ 2021-03-13T01:20:20+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/06/imc-website-300x124.png https://lifesciencesbc.ca/members/kardium-performs-first-cases-with-the-globe-positioning-system/ 2021-03-13T01:24:04+00:00 https://lifesciencesbc.ca/wp-content/uploads/2016/05/kardium-logo1.png https://lifesciencesbc.ca/members/inmed-announces-pricing-of-us8m-public-offering-and-listing-on-the-nasdaq-capital-market-under-the-symbol-inm/ 2021-03-13T01:25:10+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/the-biontech-and-pfizer-positive-covid-19-phase-3-vaccine-data-comes-with-an-important-canadian-connection/ 2021-03-13T01:26:53+00:00 https://lifesciencesbc.ca/wp-content/uploads/2017/04/Acuitas-150x150.png https://lifesciencesbc.ca/members/abcellera-discovered-antibody-receives-u-s-fda-emergency-use-authorization-as-a-monotherapy-for-the-treatment-of-covid-19/ 2021-03-13T01:27:08+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/AbCellera_Full-Colour_RGB_2-1-300x212.png https://lifesciencesbc.ca/members/aurinia-reports-third-quarter-2020-financial-results-and-recent-operational-highlights/ 2021-03-13T01:27:24+00:00 https://lifesciencesbc.ca/wp-content/uploads/2015/06/Aurinia_logo.jpg https://lifesciencesbc.ca/members/aurinia-presents-integrated-time-to-renal-response-data-from-the-aura-lv-and-aurora-trials-along-with-voclosporin-drug-drug-interaction-data-at-acr-convergence-2020/ 2021-03-13T01:28:23+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/10/Aurinia-Pharmaceuticals-300x117.png https://lifesciencesbc.ca/members/global-health-sciences-fund-quark-venture-lp-and-gf-securities-announces-portfolio-company-sqz-biotechnologies-ipo/ 2021-03-13T01:29:46+00:00 https://lifesciencesbc.ca/wp-content/uploads/2017/02/quark.png https://lifesciencesbc.ca/members/inmed-reschedules-reporting-of-first-quarter-financial-results-and-business-update-to-november-13-2020/ 2021-03-13T01:31:40+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/pharmaceuticals-to-report-first-quarter-fiscal-2021-financial-results-and-business-update-on-november-6-2020/ 2021-03-13T01:33:44+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/first-healthy-volunteer-dosed-in-symvivos-phase-1-clinical-trial-of-bactrl-spike-an-oral-covid-19-vaccine-candidate/ 2021-03-13T01:34:05+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/06/5cedd55651a2b24ba2593ad6_Symvivo-Logo-300x62.png https://lifesciencesbc.ca/members/aurinia-announces-outcome-of-audrey-clinical-trial-in-dry-eye-syndrome/ 2021-03-13T01:34:54+00:00 https://lifesciencesbc.ca/wp-content/uploads/2015/06/Aurinia_logo.jpg https://lifesciencesbc.ca/members/zucara-therapeutics-expands-zt-01-development-program-to-type-2-diabetes/ 2021-03-13T01:35:36+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/03/Zucara-300x77.jpeg https://lifesciencesbc.ca/members/alpha-9-theranostics-announces-successful-completion-of-phase-i-ii-trial-with-a9t-1101-in-patients-with-neuroendocrine-tumours-diagnostic-imaging-candidate-confirms-utility-of-bf3-technology/ 2021-03-13T01:36:02+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/10/alpha-9-300x114.png https://lifesciencesbc.ca/members/abcellera-and-kodiak-sciences-enter-second-antibody-discovery-collaboration-for-ophthalmology-targets/ 2021-03-13T01:36:37+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/08/AbCellera_Full-Colour_RGB_1-300x212.png https://lifesciencesbc.ca/members/aurinia-announces-european-investigator-initiated-trial-to-evaluate-antiviral-activity-of-voclosporin-in-kidney-transplant-recipients-with-covid-19/ 2021-03-13T01:37:30+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/10/Aurinia-Pharmaceuticals-300x117.png https://lifesciencesbc.ca/members/aurinia-presents-voclosporin-efficacy-and-pharmacokinetic-data-from-integrated-analysis-of-aura-lv-and-aurora-pivotal-trials-at-asn-kidney-week-2020/ 2021-03-13T01:39:00+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/Aurinia-logo-300x92.jpg https://lifesciencesbc.ca/members/praxis-sci-accelerate-program-applications-now-open/ 2021-03-13T01:42:32+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/10/Praxis-300x158.jpg https://lifesciencesbc.ca/members/symvivo-corporation-receives-funding-for-covid-19-vaccine-program/ 2021-03-13T01:42:48+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/03/5cedd55651a2b24ba2593ad6_Symvivo-Logo-p-1600-300x62.png https://lifesciencesbc.ca/members/sonic-incytes-announces-fda-clearance-and-us-launch-of-velacurtm-to-help-manage-emerging-health-crisis/ 2021-03-13T01:43:14+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/09/SonicIncytes-logo_color_8Sep16-300x200.jpg https://lifesciencesbc.ca/members/biolytical-laboratories-announces-launch-of-insti-1-minute-covid-19-antibody-test/ 2021-03-13T01:43:35+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/10/biolytical_to_use-150x60.gif https://lifesciencesbc.ca/members/aurinia-pharmaceuticals-announces-launch-of-lupus-nephritis-disease-state-awareness-initiative-for-healthcare-professionals-timeisnephrons-com/ 2021-03-13T01:44:24+00:00 https://lifesciencesbc.ca/members/chinook-therapeutics-closes-merger-with-aduro-biotech-and-completes-115-million-private-placement-financing/ 2021-03-15T21:51:11+00:00 https://lifesciencesbc.ca/members/derm-biome-pharmaceuticals-inc-reports-positive-results-from-a-preclinical-study-in-psoriasis/ 2021-03-15T21:52:52+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/09/Derm-Biome-Pharmaceuticals-300x106.png https://lifesciencesbc.ca/members/health-canada-certifies-winnipeg-ventilator-2-0-to-support-the-needs-of-covid-19-patients/ 2021-03-15T21:53:26+00:00 https://lifesciencesbc.ca/wp-content/uploads/2017/06/rsz_starfish_logo_400x400.jpg https://lifesciencesbc.ca/members/aurinia-announces-new-employment-inducement-grants-under-nasdaq-listing-rule-5635c4-2/ 2021-03-15T21:53:44+00:00 https://lifesciencesbc.ca/wp-content/uploads/2015/06/Aurinia_logo.jpg https://lifesciencesbc.ca/members/virogin-biotech-announces-completion-of-62-million-in-series-c-financing/ 2021-03-15T21:54:10+00:00 https://lifesciencesbc.ca/wp-content/uploads/2017/06/virogin-300x190.png https://lifesciencesbc.ca/members/immunoflex-welcomes-dr-david-macdonald-as-chief-technology-officer/ 2021-03-15T21:54:24+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/09/immunoflex-300x51.png https://lifesciencesbc.ca/members/aurinia-completes-final-patient-treatment-in-audrey-phase-2-3-clinical-trial-of-voclosporin-ophthalmic-solution-for-dry-eye-syndrome/ 2021-03-15T21:54:41+00:00 https://lifesciencesbc.ca/wp-content/uploads/2015/06/Aurinia_logo.jpg https://lifesciencesbc.ca/members/september-29-2020-zucara-therapeutics-doses-first-subject-in-phase-1-trial-of-zt-01/ 2021-03-15T21:55:03+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/03/Zucara-300x77.jpeg https://lifesciencesbc.ca/members/inmed-announces-completion-of-subject-treatments-in-second-phase-1-clinical-trial-of-inm-755-cbn-cream-in-healthy-subjects/ 2021-03-15T21:55:16+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/inmed-pharmaceuticals-announces-additional-integrasyntm-patent-filing/ 2021-03-15T21:56:32+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/interim-data-reported-for-abcellera-discovered-covid-19-antibody-in-phase-2-clinical-trials/ 2021-03-15T21:57:51+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/11/AbCellera-Logo-White-Background-150x150.png https://lifesciencesbc.ca/members/symvivo-announces-appointment-of-lloyd-mackenzie-as-president-and-chief-operating-officer/ 2021-03-15T21:58:20+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/07/5cedd55651a2b24ba2593ad6_Symvivo-Logo-1-300x62.png https://lifesciencesbc.ca/members/aurinia-pharmaceuticals-to-present-at-three-upcoming-virtual-investor-conferences/ 2021-03-15T21:58:42+00:00 https://lifesciencesbc.ca/wp-content/uploads/2015/06/Aurinia_logo.jpg https://lifesciencesbc.ca/members/kardium-marks-first-commercial-procedures-of-globe-mapping-and-ablation-system/ 2021-03-15T21:58:55+00:00 https://lifesciencesbc.ca/members/aurinia-announces-new-employment-inducement-grants-under-nasdaq-listing-rule-5635c4/ 2021-03-15T21:59:08+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-to-report-full-year-fiscal-2020-financial-results-and-business-update-on-september-8-2020/ 2021-03-15T22:00:08+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/08/inmed-300x151.png https://lifesciencesbc.ca/members/livanova-to-present-autonomic-regulation-therapy-findings-for-heart-failure-during-european-society-of-cardiology-congress-2020/ 2021-03-15T22:07:59+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/03/LIVANOVA-LOGO-150x150.png https://lifesciencesbc.ca/members/qu-biologics-is-pleased-to-announce-the-appointment-of-karn-manhas-to-qus-board-of-directors/ 2021-03-15T22:09:03+00:00 https://lifesciencesbc.ca/wp-content/uploads/2016/06/Qu_Biologics.png https://lifesciencesbc.ca/members/qu-biologics-initiates-phase-2-study-to-assess-activation-of-anti-cancer-immune-response-in-colon-cancer/ 2021-03-15T22:10:04+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/Qu-Biologics_logo.png https://lifesciencesbc.ca/members/chinook-therapeutics-announces-106-million-private-placement-financing-to-advance-precision-medicines-for-kidney-disease/ 2021-03-15T22:10:31+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/download.png https://lifesciencesbc.ca/members/aurinia-reports-second-quarter-2020-financial-results-and-recent-operational-highlights/ 2021-03-15T22:11:46+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/Aurinia-logo-web-700px.png https://lifesciencesbc.ca/members/abcellera-provides-covid-19-program-update-with-the-start-of-phase-3-clinical-trials-and-the-expansion-of-its-covid-19-antibody-database/ 2021-03-15T22:12:00+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/AbCellera_Full-Colour_RGB_2-1-300x212.png https://lifesciencesbc.ca/members/abcellera-wins-fast-companys-innovative-team-of-the-year-award-and-is-named-to-the-2020-best-workplaces-for-innovators-list/ 2021-03-15T22:12:14+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/AbCellera_Full-Colour_RGB_2-1-300x212.png https://lifesciencesbc.ca/members/novateur-ventures-explores-new-strategy-to-reduce-the-hyperinflammatory-response-caused-by-covid-19/ 2021-03-15T22:13:43+00:00 https://lifesciencesbc.ca/wp-content/uploads/2017/12/Novateur-300x101.png https://lifesciencesbc.ca/members/aurinia-pharmaceuticals-to-present-at-the-btig-virtual-biotechnology-conference/ 2021-03-15T22:14:20+00:00 https://lifesciencesbc.ca/members/aurinia-pharmaceuticals-to-report-second-quarter-2020-financial-results-on-august-11-2020/ 2021-03-15T22:15:11+00:00 https://lifesciencesbc.ca/wp-content/uploads/2015/06/Aurinia_logo.jpg https://lifesciencesbc.ca/members/health-research-foundation-awards-research-chair-in-pandemic-preparedness-research-to-ubc-professor/ 2021-03-15T22:15:59+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/05/IMC-Logo-300x124.png https://lifesciencesbc.ca/members/health-canada-grants-marketing-authorization-with-conditions-noc-c-for-gileads-veklury-remdesivir-for-the-treatment-of-coronavirus-disease-2019-covid-19/ 2021-03-15T22:16:41+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/03/gilead-sciences-300x84.png https://lifesciencesbc.ca/members/aurinia-closes-us200-million-public-offering-of-common-shares/ 2021-03-15T22:16:56+00:00 https://lifesciencesbc.ca/wp-content/uploads/2015/06/Aurinia_logo.jpg https://lifesciencesbc.ca/members/aurinia-prices-us200-million-public-offering-of-common-shares/ 2021-03-15T22:17:14+00:00 https://lifesciencesbc.ca/wp-content/uploads/2015/06/Aurinia_logo.jpg https://lifesciencesbc.ca/members/aurinia-announces-public-offering-of-common-shares/ 2021-03-15T22:17:52+00:00 https://lifesciencesbc.ca/wp-content/uploads/2015/06/Aurinia_logo.jpg https://lifesciencesbc.ca/members/aurinia-announces-u-s-food-and-drug-administration-acceptance-of-the-filing-of-new-drug-application-and-priority-review-for-voclosporin-for-the-treatment-of-lupus-nephritis/ 2021-03-15T22:18:52+00:00 https://lifesciencesbc.ca/wp-content/uploads/2015/06/Aurinia_logo.jpg https://lifesciencesbc.ca/members/livanova-announces-commercial-launch-of-perceval-plus-aortic-heart-valve-in-europe/ 2021-03-15T22:19:31+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/03/LIVANOVA-LOGO-300x300.png https://lifesciencesbc.ca/members/canadian-consortium-increases-access-to-cancer-testing-and-treatment-in-response-to-covid-19/ 2021-03-15T22:20:14+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/07/canexia-logo.png https://lifesciencesbc.ca/members/livanova-announces-publication-detailing-the-design-of-the-recover-clinical-study-evaluating-vns-therapy-for-treatment-resistant-depression/ 2021-03-15T22:21:28+00:00 https://lifesciencesbc.ca/members/zymeworks-announces-new-multispecific-antibody-collaboration-with-merck/ 2021-03-15T22:21:43+00:00 https://lifesciencesbc.ca/wp-content/uploads/2016/05/558px-Zymeworks_Logo.svg-300x135.png https://lifesciencesbc.ca/members/entrepreneurshipubc-lab2launch-venture-building-program/ 2021-03-15T22:22:24+00:00 https://lifesciencesbc.ca/wp-content/uploads/2016/08/ubc-300x102.png https://lifesciencesbc.ca/members/genome-british-columbia-annual-report-for-the-fiscal-year-2019-2020-celebrating-our-20th-anniversary/ 2021-03-15T22:22:39+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/01/Genome-BC_Logo-20th-300x133.png https://lifesciencesbc.ca/members/inmed-announces-dosing-initiation-in-2nd-phase-1-trial-with-inm-755/ 2021-03-15T22:23:05+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/inmed-announces-completion-of-share-consolidation/ 2021-03-15T22:23:24+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/kardium-receives-ce-mark-for-globe-mapping-and-ablation-system-announces-launch-of-commercial-sales-in-europe/ 2021-03-15T22:23:53+00:00 https://lifesciencesbc.ca/wp-content/uploads/2016/05/kardium-logo1.png https://lifesciencesbc.ca/members/canadian-firm-plays-key-role-in-covid-19-vaccine-development-project-with-biontech-and-pfizer/ 2021-03-15T22:24:12+00:00 https://lifesciencesbc.ca/wp-content/uploads/2017/04/Acuitas-300x247.png https://lifesciencesbc.ca/members/msfhr-funds-covid-19-research-to-mitigate-effects-on-bcs-vulnerable-populations/ 2021-03-15T22:24:46+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/08/MSFHR-logo-new-300x131.jpg https://lifesciencesbc.ca/members/inmed-introduces-integrasyntm-an-integrated-cannabinoid-manufacturing-system/ 2021-03-15T22:25:42+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/aurinia-completes-patient-enrollment-into-the-audrey-phase-2-3-clinical-trial-of-voclosporin-ophthalmic-solution-for-the-treatment-of-dry-eye-syndrome/ 2021-03-15T22:26:39+00:00 https://lifesciencesbc.ca/wp-content/uploads/2015/06/Aurinia_logo.jpg https://lifesciencesbc.ca/members/inmed-announces-filing-of-registration-statement-in-connection-with-united-states-offering-application-to-seek-nasdaq-listing-and-planned-share-consolidation/ 2021-03-15T22:27:02+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/imc-responds-to-the-release-of-revised-pmprb-guidelines/ 2021-03-15T22:27:56+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/08/IMC-Logo-300x124.png https://lifesciencesbc.ca/members/minister-bains-announces-members-of-new-industry-strategy-council/ 2021-03-15T22:28:33+00:00 https://lifesciencesbc.ca/wp-content/uploads/2017/02/quark.png https://lifesciencesbc.ca/members/microdermics-inc-seeks-to-commercialize-microneedle-drug-delivery-biosensing-technology/ 2021-03-15T22:29:04+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/11/NOVATEUR-300x120.jpg https://lifesciencesbc.ca/members/aurinia-presents-additional-aurora-pivotal-trial-safety-data-at-the-era-edta-virtual-congress-2020/ 2021-03-15T22:30:06+00:00 https://lifesciencesbc.ca/members/aurinia-presents-aurora-pivotal-trial-subgroup-analysis-at-the-eular-2020-e-congress/ 2021-03-15T22:30:21+00:00 https://lifesciencesbc.ca/wp-content/uploads/2015/06/Aurinia_logo.jpg https://lifesciencesbc.ca/members/aurinia-announces-results-of-annual-general-meeting/ 2021-03-15T22:30:54+00:00 https://lifesciencesbc.ca/members/aduro-biotech-and-chinook-therapeutics-announce-definitive-merger-agreement/ 2021-03-15T22:32:05+00:00 https://lifesciencesbc.ca/members/aurinia-pharmaceuticals-to-present-at-the-jefferies-virtual-healthcare-conference/ 2021-03-15T22:32:20+00:00 https://lifesciencesbc.ca/wp-content/uploads/2015/06/Aurinia_logo.jpg https://lifesciencesbc.ca/members/aurinia-completes-submission-of-new-drug-application-to-the-u-s-food-drug-administration-for-voclosporin-for-the-treatment-of-lupus-nephritis/ 2021-03-15T22:33:11+00:00 https://lifesciencesbc.ca/wp-content/uploads/2015/06/Aurinia_logo.jpg https://lifesciencesbc.ca/members/signalchem-biotech-inc-launches-covid-19-elisa-kits-for-diagnostic-research/ 2021-03-15T22:34:24+00:00 https://lifesciencesbc.ca/members/inmed-releases-cbn-preclinical-results-in-glaucoma/ 2021-03-15T22:34:41+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/imc-announces-creation-of-research-chair-in-pandemic-preparedness/ 2021-03-15T22:34:58+00:00 https://lifesciencesbc.ca/members/artms-closes-a-us19-million-series-a-financing-with-deerfield-and-global-health-sciences-ghs-fund/ 2021-03-15T22:36:13+00:00 https://lifesciencesbc.ca/wp-content/uploads/2017/02/quark.png https://lifesciencesbc.ca/members/alpha-9-theranostics-appoints-simon-pimstone-michael-reitermann-to-board-of-directors/ 2021-03-15T22:37:07+00:00 https://lifesciencesbc.ca/members/cansino-biologics-and-precision-nanosystems-announce-collaboration-to-co-develop-a-covid-19-rna-vaccine/ 2021-03-15T22:37:43+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-continues-to-strengthen-biosynthesis-patent-family/ 2021-03-15T22:38:25+00:00 https://lifesciencesbc.ca/members/qu-biologics-first-in-class-platform-technology-uniquely-positioned-to-address-the-covid-19-pandemic-by-arming-the-innate-immune-system-our-first-line-of-defense/ 2021-03-15T22:39:07+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/11/Qu-Biologics-Inc.-300x104.png https://lifesciencesbc.ca/members/pharmaceuticals-reports-third-quarter-fiscal-2020-financial-results-and-provides-rd-and-business-update/ 2021-03-15T22:40:11+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/inmed-pharmaceuticals-to-report-third-quarter-fiscal-2020-financial-results-and-business-update-on-may-14-2020/ 2021-03-15T22:40:43+00:00 https://lifesciencesbc.ca/members/inmed-files-pct-patent-application-for-neuroprotection-in-glaucoma/ 2021-03-15T22:41:01+00:00 https://lifesciencesbc.ca/members/inmed-to-present-at-canaccord-genuitys-4th-annual-cannabis-conference/ 2021-03-15T22:42:20+00:00 https://lifesciencesbc.ca/members/inmed-receives-cta-approval-for-second-phase-1-clinical-trial-with-inm-755/ 2021-03-15T22:42:41+00:00 https://lifesciencesbc.ca/members/variational-ai-receives-support-from-the-digital-technology-supercluster-for-repurposing-of-drugs-for-covid-19/ 2021-03-15T22:43:07+00:00 https://lifesciencesbc.ca/members/microbiome-insights-recognized-for-the-fourth-consecutive-year-in-list-of-bcs-top-emerging-life-sciences-companies/ 2021-03-15T22:44:37+00:00 https://lifesciencesbc.ca/members/livleen-veslemes-named-change-maker-of-the-year-by-bcbusiness-magazine/ 2021-03-15T22:46:24+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/biolytical_to_use.gif https://lifesciencesbc.ca/members/introducing-cytiva-global-life-sciences-leader/ 2021-03-15T22:46:43+00:00 https://lifesciencesbc.ca/members/msfhr-launches-covid-19-research-response-fund-first-call-for-proposals/ 2021-03-15T22:47:07+00:00 https://lifesciencesbc.ca/members/qu-biologics-publishes-landmark-studies-showing-cells-of-the-innate-immune-system-can-be-directed-to-target-organ-sites-to-prevent-and-clear-pathology-and-infection/ 2021-03-15T22:47:28+00:00 https://lifesciencesbc.ca/members/innovative-medicines-canada-members-donate-100000-masks-to-help-protect-front-line-healthcare-workers-battling-covid-19/ 2021-03-15T22:47:54+00:00 https://lifesciencesbc.ca/members/inmed-announces-completion-of-initial-phase-1-clinical-trial-of-inm-755-cbn-cream-in-healthy-subjects/ 2021-03-15T22:48:23+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/aurinia-announces-aurora-phase-3-clinical-data-for-voclosporin-in-lupus-nephritis-to-be-presented-at-national-kidney-foundation-2020-spring-clinical-meetings/ 2021-03-15T22:52:16+00:00 https://lifesciencesbc.ca/members/covid-19-working-together-on-a-solution/ 2021-03-15T22:54:11+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/08/IMC-Logo-300x124.png https://lifesciencesbc.ca/members/abcellera-and-lilly-to-co-develop-antibody-therapies-for-the-treatment-of-covid-19/ 2021-03-15T22:56:41+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-announces-completed-enrollment-in-phase-1-clinical-trial-of-inm-755-cbn-cream-in-healthy-subjects/ 2021-03-15T22:57:03+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/abcellera-partnership-to-provide-next-generation-therapeutic-antibody-discovery/ 2021-03-15T22:57:52+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-reports-second-quarter-fiscal-2020-financial-results-and-provides-rd-and-business-update/ 2021-03-15T23:00:06+00:00 https://lifesciencesbc.ca/members/global-health-sciences-fund-quark-venture-lp-and-gf-securities-contributes-to-volastra-therapeutics-12-million-seed-financing-for-companys-development-of-novel-metastatic-cancer-t/ 2021-03-15T23:00:41+00:00 https://lifesciencesbc.ca/members/dr-chonnettia-jones-joins-msfhr-as-vice-president-research/ 2021-03-15T23:01:54+00:00 https://lifesciencesbc.ca/members/global-health-sciences-fund-quark-venture-lp-and-gf-securities-participates-in-22-million-series-c-preferred-stock-financing-in-raziel-therapeutics-for-development-of-an-orphan-drug-treating-fat-di/ 2021-03-15T23:02:36+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-to-present-at-the-biotech-showcase-conference/ 2021-03-15T23:03:35+00:00 https://lifesciencesbc.ca/members/inmed-announces-election-of-directors/ 2021-03-15T23:03:52+00:00 https://lifesciencesbc.ca/members/inmed-expands-on-announcement-of-cannabinol-cbn-therapeutic-leadership-with-new-website-content-and-ceo-interview/ 2021-03-15T23:04:46+00:00 https://lifesciencesbc.ca/members/inmed-first-to-advance-cannabinol-cbn-into-therapeutic-clinical-trials/ 2021-03-15T23:05:05+00:00 https://lifesciencesbc.ca/members/chinook-therapeutics-obtains-worldwide-rights-from-abbvie-to-atrasentan-with-plans-to-develop-for-the-treatment-of-kidney-diseases/ 2021-03-15T23:05:32+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-to-attend-and-exhibit-at-eb2020-world-congress/ 2021-03-15T23:05:53+00:00 https://lifesciencesbc.ca/members/onestep-laboratories-developed-quickredtm-the-first-small-molecular-near-infrared-nucleus-stain-for-living-cell-imaging/ 2021-03-15T23:06:18+00:00 https://lifesciencesbc.ca/members/admare-bioinnovations-and-accel-rx-unite-to-advance-the-canadian-life-sciences-sector/ 2021-03-15T23:06:57+00:00 https://lifesciencesbc.ca/members/global-health-sciences-fund-quark-venture-lp-and-gf-securities-participate-in-eyevensys-usd-30-million-series-b-financing-for-development-of-ocular-platform/ 2021-03-15T23:07:42+00:00 https://lifesciencesbc.ca/members/qu-biologics-completes-enrollment-in-first-stage-of-phase-2-clinical-trial-in-moderate-to-severe-crohns-disease/ 2021-03-15T23:08:04+00:00 https://lifesciencesbc.ca/members/inmed-receives-clinical-trial-application-approval-for-inm-755-a-rare-cannabinoid-formulation-under-development-for-the-treatment-of-epidermolysis-bullosa/ 2021-03-15T23:09:15+00:00 https://lifesciencesbc.ca/members/aurinia-closes-us191-7-million-public-offering-of-common-shares-and-full-exercise-of-underwriters-option-to-purchase-additional-common-shares/ 2021-03-15T23:09:47+00:00 https://lifesciencesbc.ca/members/aurinia-announces-positive-aurora-phase-3-trial-results-demonstrating-voclosporin-superiority-over-standard-of-care-in-lupus-nephritis/ 2021-03-15T23:12:21+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-reports-first-quarter-fiscal-2020-financial-results-and-provides-rd-and-business-update/ 2021-03-15T23:15:44+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-to-present-at-the-cowen-conference/ 2021-03-15T23:16:27+00:00 https://lifesciencesbc.ca/members/signalchem-initiates-phase-1-clinical-trial-for-slc-391-in-subjects-with-solid-tumours/ 2021-03-15T23:17:11+00:00 https://lifesciencesbc.ca/members/inmed-submits-clinical-trial-application-to-evaluate-inm-755-in-phase-1-trial/ 2021-03-15T23:19:19+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-to-report-first-quarter-fiscal-2020-financial-results-and-business-update-on-november-8-2019/ 2021-03-15T23:19:49+00:00 https://lifesciencesbc.ca/members/innovative-targeting-solutions-and-former-amgen-executive-team-up-to-launch-a2-biotherapeutics-with-a-57-million-series-a/ 2021-03-15T23:20:07+00:00 https://lifesciencesbc.ca/members/precision-nanosystems-to-launch-the-revolutionary-ignite-a-disruptive-technology-enabling-transformative-medicine/ 2021-03-15T23:20:45+00:00 https://lifesciencesbc.ca/members/abcellera-named-one-of-canadas-top-growing-companies/ 2021-03-15T23:20:58+00:00 https://lifesciencesbc.ca/members/abcellera-appoints-andrew-booth-as-chief-financial-officer-and-tryn-stimart-as-general-counsel/ 2021-03-15T23:22:34+00:00 https://lifesciencesbc.ca/members/chinook-therapeutics-raises-65-million-series-a-financing-to-advance-precision-medicines-for-kidney-diseases/ 2021-03-15T23:22:52+00:00 https://lifesciencesbc.ca/members/qu-biologics-publishes-potentially-paradigm-shifting-results-of-their-first-randomized-placebo-controlled-trial-for-the-treatment-of-crohns-disease/ 2021-03-15T23:24:30+00:00 https://lifesciencesbc.ca/members/vitaeris-announces-multiple-scientific-presentations-involving-clazakizumab-at-the-2019-american-transplant-congress/ 2021-03-15T23:26:17+00:00 https://lifesciencesbc.ca/members/nz-technologies-announces-third-peer-reviewed-paper-on-tipso-touchless-image-navigation-builds-evidence-for-a-technology-platform-designed-for-the-or-of-the-future/ 2021-03-15T23:26:46+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/06/NZ-300x40-300x40.png https://lifesciencesbc.ca/members/touchless-image-navigation-facilitates-decision-making-in-the-operating-room/ 2021-03-15T23:27:01+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/06/NZ-300x40-300x40.png https://lifesciencesbc.ca/members/virogin-biotech-to-form-a-joint-venture-with-chinas-largest-pharmaceutical-company-to-commercialize-oncolytic-virotherapies/ 2021-03-15T23:29:07+00:00 https://lifesciencesbc.ca/members/onestep-laboratories-received-a-china-patent-cn107449902-potential-to-monitor-chlorine-in-dialysis-for-kidney-failure/ 2021-03-15T23:30:24+00:00 https://lifesciencesbc.ca/members/phyton-biotech-partners-with-agenus-to-revolutionize-qs-21-production/ 2021-03-15T23:38:31+00:00 https://lifesciencesbc.ca/members/inmed-to-present-at-virtual-conferences-in-march-2021/ 2021-03-25T04:14:20+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/INMED%20PHARMA.jpg https://lifesciencesbc.ca/wp-content/uploads/2018/08/inmed-300x151.png https://lifesciencesbc.ca/ecosystem/ubc-faculty-of-medicine-researchers-receive-more-than-5m-from-u-s-department-of-defense-spinal-cord-injury-research-program/ 2021-03-25T04:40:17+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/UBC-Faculty-of-Medicine-1.jpg https://lifesciencesbc.ca/ecosystem/different-strokes-new-software-advances-ability-to-turn-stem-cells-into-other-cell-types/ 2021-03-25T04:40:20+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/BioLinks-March-18-2.jpg https://lifesciencesbc.ca/ecosystem/winnipeg-lab-that-confirmed-canadas-1st-covid-19-case-now-working-on-vaccines-tracing-virus-in-wastewater/ 2021-03-25T04:47:11+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/BioLinks-March-18-1.png https://lifesciencesbc.ca/members/doctors-of-bc-2020-awards-honouring-bcs-outstanding-doctors/ 2021-04-08T16:51:20+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Thrive-Health-1.jpg https://lifesciencesbc.ca/members/chinook-therapeutics-announces-update-on-non-renal-legacy-programs-from-aduro-biotech-merger/ 2021-04-08T17:10:15+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/CHINOOK-THERAPEUTICS.jpg https://lifesciencesbc.ca/members/aurinia-presents-data-demonstrating-lupkynis-voclosporin-efficacy-across-lupus-nephritis-biopsy-classes-at-national-kidney-foundation-2021-spring-clinical-meetings/ 2021-04-15T23:38:58+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/Aurinia.jpg https://lifesciencesbc.ca/members/aurinia-pharmaceuticals-to-present-at-the-bloom-burton-co-healthcare-investor-conference/ 2021-04-15T23:51:19+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/Aurinia.jpg https://lifesciencesbc.ca/members/northview-congratulates-portfolio-company-perimeter-medical-imaging-ai-inc-on-fda-breakthrough-device-designation/ 2021-04-16T17:11:56+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/Northview-LifeSciences.png https://lifesciencesbc.ca/members/genome-bc-launches-rapid-response-funding-for-covid-19-projects/ 2021-04-19T19:43:21+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/03/Genome-BC_Logo-20th.png https://lifesciencesbc.ca/members/ico-therapeutics-inc-announces-upsized-subscription-receipt-private-placement/ 2021-04-23T19:40:21+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/ICO-THERAPEUTICS-300x200.png https://lifesciencesbc.ca/ecosystem/new-training-program-to-help-fill-bioscience-job-vacancies-on-p-e-i/ 2021-04-24T01:10:08+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/BioLinks-March-26.jpg https://lifesciencesbc.ca/ecosystem/win-3000-award-in-the-praxis-ideation-challenge/ 2021-04-24T01:15:38+00:00 https://lifesciencesbc.ca/ecosystem/government-sanofi-officials-unveil-925m-in-vaccine-funding-in-toronto/ 2021-04-24T01:17:28+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/BioLinks-April-1.jpg https://lifesciencesbc.ca/ecosystem/techcouver-features-abozymes-biomedical-as-startup-of-the-week/ 2021-04-24T01:24:22+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/BioLinks-April-9-e1619227432246.png https://lifesciencesbc.ca/ecosystem/council-of-canadian-innovators-expands-to-ontario-alberta-and-b-c/ 2021-04-24T01:34:05+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/BioLinks-April-15-e1619228012648.jpg https://lifesciencesbc.ca/ecosystem/study-suggests-vaccines-may-improve-symptoms-for-some-covid-19-long-haulers/ 2021-04-24T01:34:35+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/BioLinks-April-15-1.jpg https://lifesciencesbc.ca/ecosystem/u-s-study-identifies-the-genes-that-fight-coronavirus-infections/ 2021-04-24T01:56:33+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/BioLinks-April-22-e1619228112746.jpg https://lifesciencesbc.ca/ecosystem/sonic-incytes-hosts-redefining-the-standard-of-care-for-assessing-liver-health-webinar/ 2021-04-24T02:04:05+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/Sonic-Incytes.jpg https://lifesciencesbc.ca/ecosystem/newest-lupus-drug-in-60-years-discovered-in-canada-approved-in-usa/ 2021-04-24T02:38:40+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/API-Logo.jpg https://lifesciencesbc.ca/ecosystem/vancouver-startup-week-is-back-for-its-8th-consecutive-year-this-may/ 2021-04-24T02:54:30+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/vsw-logo-full-e1619232835901.png https://lifesciencesbc.ca/members/inmed-pharmaceuticals-announces-voluntary-delisting-from-tsx/ 2021-04-27T17:46:39+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/INMED-PHARMA.jpg https://lifesciencesbc.ca/members/inmed-pharmaceuticals-submits-clinical-trial-applications-to-evaluate-inm-755-cannabinol-cream-in-a-phase-2-trial-for-epidermolysis-bullosa/ 2021-04-28T17:26:18+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/INMED-PHARMA.jpg https://lifesciencesbc.ca/members/precision-piezo-motion-without-the-premium-price-tag-thursday-may-6th-at-8am-pst/ 2021-05-03T22:28:53+00:00 https://lifesciencesbc.ca/members/inmed-to-present-at-canaccord-genuitys-5th-annual-global-cannabis-conference-on-may-11th-2021/ 2021-05-04T19:27:22+00:00 https://lifesciencesbc.ca/members/axolotl-bioscience-selected-to-participate-in-cta-2021/ 2021-05-04T23:10:55+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/cspc-1-1.png https://lifesciencesbc.ca/ecosystem/13th-annual-cspc/ 2021-05-04T23:17:03+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/cspc-.png https://lifesciencesbc.ca/members/rsvp-for-the-2021-investor-showcase-presented-by-hatch-entrepreneurshipubc-and-icics/ 2021-05-05T20:25:05+00:00 https://lifesciencesbc.ca/ecosystem/trial-of-covid-19-treatment-drug-expanded-to-include-all-of-fraser-health/ 2021-05-05T20:34:42+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/bamlanivimab.jpeg https://lifesciencesbc.ca/ecosystem/500-million-investment-fund-paves-way-for-a-strongerbc/ 2021-05-05T21:39:08+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/proxy-e1620078748680.jpeg https://lifesciencesbc.ca/ecosystem/covid-19-pregnant-women-in-b-c-now-prioritized-for-vaccine/ 2021-05-05T23:48:37+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/Pregnancy-COVID-Shot.jpg https://lifesciencesbc.ca/ecosystem/ubc-researchers-unveil-first-molecular-images-of-b-1-1-7-covid-19-mutation/ 2021-05-06T23:01:19+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/may-6th-NL-Photo.png https://lifesciencesbc.ca/members/apply-to-the-lumira-ventures-venture-innovation-program/ 2021-05-06T23:46:16+00:00 https://lifesciencesbc.ca/members/amgen-announces-tezepelumab-biologics-license-application-submitted-to-u-s-fda/ 2021-05-10T18:38:27+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/AMGEN%20BC.jpg https://lifesciencesbc.ca/ecosystem/fda-approves-100th-monoclonal-antibody-product/ 2021-05-12T18:57:37+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/FDA-May-7th.jpg https://lifesciencesbc.ca/members/inmed-pharmaceuticals-to-report-third-quarter-fiscal-2021-financial-results/ 2021-05-12T23:38:27+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/INMED-PHARMA.jpg https://lifesciencesbc.ca/members/qu-biologics-files-important-new-ip-for-the-treatment-of-post-surgical-immune-dysfunction-and-prevention-of-cancer-metastasis/ 2021-05-14T18:08:24+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/Copy-of-Qu-Biologics-Logo-resized-.png https://lifesciencesbc.ca/ecosystem/the-bc-2021-women-of-the-year-awards-corporate-leader/ 2021-05-14T23:01:11+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/BC-Business-logo.jpg https://lifesciencesbc.ca/ecosystem/bc-government-news-reports-people-with-als-will-benefit-from-research-clinical-trials/ 2021-05-17T16:53:10+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/BC-government-logo.png https://lifesciencesbc.ca/members/acuitas-announces-nature-publication-with-verve-therapeutics-demonstrating-potent-and-durable-low-density-lipoprotein-cholesterol-reduction-in-non-human-primates-after-a-gene-editing-treatm/ 2021-05-19T19:44:55+00:00 https://lifesciencesbc.ca/ecosystem/federal-government-invests-200-million-to-build-an-mrna-vaccine-plant-in-ontario/ 2021-05-19T21:57:21+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/mRNA-200Mill.png https://lifesciencesbc.ca/members/bc-research-funding-collaboration-supports-critical-covid-19-vaccine-research/ 2021-05-20T19:14:27+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/msfhr.jpg https://lifesciencesbc.ca/ecosystem/carbohydrate-cage-allows-precise-drug-delivery-to-the-gastrointestinal-tract/ 2021-05-20T22:22:11+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Industry-News.jpg https://lifesciencesbc.ca/ecosystem/b-c-to-announce-plans-for-vaccinating-children-aged-12-17/ 2021-05-20T23:31:02+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/vaccine-kids.jpg https://lifesciencesbc.ca/ecosystem/covid-vaccine-made-by-canadas-medicago-shows-promising-results-in-phase-2-clinical-trial/ 2021-05-21T16:54:07+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/may-21.png https://lifesciencesbc.ca/members/zucara-therapeutics-successfully-completes-single-and-multiple-ascending-dose-phase-1-trial-of-zt-01/ 2021-05-26T17:36:30+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Zucara-Therapeutics-Inc..jpg https://lifesciencesbc.ca/members/uk-clinical-trial-confirms-sanotizes-breakthrough-treatment-for-covid-19/ 2021-05-27T17:58:20+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Sanotize.jpg https://lifesciencesbc.ca/members/fda-grants-bold-therapeutics-bold-100-an-orphan-drug-designation-odd-in-the-treatment-of-gastric-cancer/ 2021-05-27T18:52:45+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/BOLD%20THERAPEUTICS.jpg https://lifesciencesbc.ca/members/national-research-council-of-canada-supports-development-of-4-covid-19-therapeutic-candidates/ 2021-05-27T19:00:40+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/12/Bold_Logo.png https://lifesciencesbc.ca/members/bold-therapeutics-successfully-initiates-clinical-trial-of-first-in-class-anti-cancer-agent-bold-100/ 2021-05-27T19:01:04+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/10/Bold_Logo-300x93.png https://lifesciencesbc.ca/members/bold-100-significantly-outperforms-remdesivir-head-to-head-in-sars-cov-2-covid-19-model/ 2021-05-27T19:01:23+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/100.jpg https://lifesciencesbc.ca/members/bold-100-demonstrates-nanomolar-range-inhibition-of-live-covid-19-in-vitro/ 2021-05-27T19:01:39+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/10/Bold_Logo-300x93.png https://lifesciencesbc.ca/members/bold-therapeutics-expands-covid-19-consortium/ 2021-05-27T19:02:05+00:00 https://lifesciencesbc.ca/members/bold-therapeutics-executes-option-agreement-for-exclusive-development-and-commercialization-rights-to-bold-100-in-south-korea/ 2021-05-27T19:02:17+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/10/Bold_Logo-300x93.png https://lifesciencesbc.ca/members/bold-therapeutics-seeks-collaborators-for-rapid-development-of-bold-100-lead-drug-candidate-has-potential-utility-in-the-treatment-of-covid-19/ 2021-05-27T19:02:29+00:00 https://lifesciencesbc.ca/members/bold-therapeutics-to-initiate-phase-1b-trial-of-bold-100-in-the-treatment-of-gi-cancers/ 2021-05-27T19:02:41+00:00 https://lifesciencesbc.ca/members/life-sciences-see-silver-lining-in-dark-covid-clouds/ 2021-05-27T19:34:01+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Sanotize.jpg https://lifesciencesbc.ca/members/zymeworks-to-present-at-jefferies-virtual-healthcare-conference/ 2021-05-27T22:30:09+00:00 https://lifesciencesbc.ca/members/fda-clears-zanidatamab-phase-3-pivotal-trial-in-first-line-her2-positive-gastroesophageal-adenocarcinoma-gea/ 2021-05-27T22:37:29+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/Zymeworks-Inc..jpg https://lifesciencesbc.ca/members/inmed-pharmaceuticals-reports-third-quarter-fiscal-2021-financial-results/ 2021-05-27T22:39:41+00:00 https://lifesciencesbc.ca/members/xco-tech-inc-and-atlazo-announce-joint-venture-to-commercialize-virtual-healthcare-products-leveraging-edge-ai-system-on-chip-technology/ 2021-05-27T22:40:11+00:00 https://lifesciencesbc.ca/members/ico-therapeutics-subsidiary-to-present-oral-amphotericin-b-sars-cov-2-research-results-at-national-pharmaceutical-sciences-meeting/ 2021-05-27T22:40:57+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/ICO-THERAPEUTICS-300x200.png https://lifesciencesbc.ca/members/abcellera-partners-with-angios-to-develop-therapeutics-to-combat-blindness-caused-by-diabetic-retinopathy/ 2021-05-27T22:41:36+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Abcellera-1.jpg https://lifesciencesbc.ca/members/fda-accepts-amgens-supplemental-new-drug-application-for-otezla-apremilast-for-adults-with-mild-to-moderate-plaque-psoriasis/ 2021-05-27T22:41:56+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/AMGEN%20BC.jpg https://lifesciencesbc.ca/members/starfish-medical-presents-free-90-minute-webinar-about-human-factors/ 2021-05-27T22:42:11+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Starfish-Medical.jpg https://lifesciencesbc.ca/members/abcellera-discovered-antibody-that-neutralizes-viral-variants-of-covid-19-ly-cov1404-enters-clinical-trials/ 2021-05-27T22:42:26+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/Abcellera.jpg https://lifesciencesbc.ca/members/meeting-the-covid-19-challenge/ 2021-05-27T22:43:55+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/GENOME-BC.jpg https://lifesciencesbc.ca/members/vantec-meeting-investing-in-life-sciences-and-healthtech/ 2021-05-27T23:23:46+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/vantec-edited.png https://lifesciencesbc.ca/members/register-for-advances-in-nash-drugs-the-role-of-nits-webinar-june-10/ 2021-05-28T19:16:30+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/June-10-Webinar-Ad-Full_website.jpg https://lifesciencesbc.ca/members/roche-canada-announces-collaboration-to-improve-access-to-personalized-healthcare-with-real-world-evidence/ 2021-05-28T19:48:07+00:00 https://lifesciencesbc.ca/members/admare-and-aazeintx-inc-sign-global-exclusive-agreement-for-promising-acute-asthma-treatment-neo6860/ 2021-05-31T20:29:14+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/adMare303x237.png https://lifesciencesbc.ca/members/kintara-therapeutics-appoints-dr-mario-lacouture-to-scientific-advisory-board-for-cutaneous-metastatic-breast-cancer/ 2021-05-31T20:58:27+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/KINTARA%20THERAPEUTICS.jpg https://lifesciencesbc.ca/wp-content/uploads/2020/09/kintara-logo-300x83.png https://lifesciencesbc.ca/members/kintara-therapeutics-to-present-at-the-h-c-wainwright-global-life-sciences-conference/ 2021-05-31T20:58:28+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/09/kintara-logo-300x83.png https://lifesciencesbc.ca/members/kintara-therapeutics-enrolls-final-patient-in-phase-2-clinical-trial-of-val-083-for-recurrent-gbm/ 2021-05-31T20:58:28+00:00 https://lifesciencesbc.ca/members/kintara-therapeutics-announces-first-fiscal-quarter-2021-financial-results-and-recent-corporate-updates/ 2021-05-31T20:58:29+00:00 https://lifesciencesbc.ca/members/kintara-therapeutics-announces-fiscal-year-2020-financial-results-and-recent-corporate-updates/ 2021-05-31T20:58:29+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/09/kintara-logo-300x83.png https://lifesciencesbc.ca/members/kintara-therapeutics-reports-10-months-progression-free-survival-in-newly-diagnosed-mgmt-unmethylated-gbm-from-ongoing-md-anderson-cancer-center-phase-2-study/ 2021-05-31T20:58:29+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/09/kintara-logo-300x83.png https://lifesciencesbc.ca/members/kintara-and-the-global-coalition-for-adaptive-research-execute-agreement-for-val-083s-participation-in-the-gbm-agile-registrational-study/ 2021-05-31T20:58:29+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/09/kintara-logo-300x83.png https://lifesciencesbc.ca/members/kintara-therapeutics-to-present-at-the-2nd-annual-glioblastoma-drug-development-summit/ 2021-05-31T20:58:29+00:00 https://lifesciencesbc.ca/members/kintara-therapeutics-formerly-delmar-pharmaceuticals-announces-completion-of-merger-with-adgero-biopharmaceuticals-and-closing-of-19-6-million-private-placement-priced-at-the-market/ 2021-05-31T20:58:30+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/logo-600px@2x.png https://lifesciencesbc.ca/members/kintara-therapeutics-formerly-delmar-pharmaceuticals-regains-compliance-with-nasdaq-minimum-bid-price-requirement/ 2021-05-31T20:58:30+00:00 https://lifesciencesbc.ca/members/kintara-therapeutics-announces-closing-of-additional-2-2-million-private-placement-priced-at-the-market/ 2021-05-31T20:58:30+00:00 https://lifesciencesbc.ca/members/kintara-therapeutics-formerly-delmar-pharmaceuticals-to-present-at-the-ld-micro-500-virtual-conference-on-september-3rd-2020/ 2021-05-31T20:58:30+00:00 https://lifesciencesbc.ca/members/kintara-therapeutics-completes-final-closing-of-previously-announced-private-placement-for-an-aggregate-of-25-million/ 2021-05-31T20:58:30+00:00 https://lifesciencesbc.ca/members/organoids-market-is-expected-to-reach-us-3420-40-million-by-2027-with-stemcell-technologies/ 2021-05-31T21:15:46+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/Stemcell.jpg https://lifesciencesbc.ca/ecosystem/entrepreneurshipubc-launches-human-health-venture-studio/ 2021-05-31T21:17:53+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/entrepreneurship@UBC.jpg https://lifesciencesbc.ca/members/ico-therapeutics-inc-announces-that-oral-amphotericin-b-ico-019-results-will-be-highlighted-during-the-american-association-of-pharmaceutical-scientists-aaps-virtual-meeting-october-26-november/ 2021-05-31T21:18:27+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/07/ICO-THERAPEUTICS-300x200.png https://lifesciencesbc.ca/members/xenon-provides-key-regulatory-updates-on-xen007-and-xen1101/ 2021-05-31T21:20:28+00:00 https://lifesciencesbc.ca/members/algernon-pharmaceuticals-highlights-new-animal-study-showing-effectiveness-of-psychedelic-drug-dmt-in-treatment-of-stroke/ 2021-06-02T16:46:08+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/ALGERNON%20PHARMACEUTICALS.jpg https://lifesciencesbc.ca/members/derm-biome-pharmaceuticals-inc-adds-skin-disease-and-microbiome-specialists-drs-youwen-zhou-and-andy-sham-to-its-newly-created-scientific-advisory-board/ 2021-06-02T17:31:58+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/DERM%20BIOME.jpg https://lifesciencesbc.ca/members/precision-nanosystems-joins-danahers-life-sciences-platform/ 2021-06-02T21:52:55+00:00 https://lifesciencesbc.ca/members/applications-are-now-open-for-the-2021-2022-admare-executive-institute/ 2021-06-02T22:48:41+00:00 https://lifesciencesbc.ca/members/blakes-named-canada-banking-finance-firm-of-the-year-2/ 2021-06-03T18:47:41+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/BLAKES-1.jpg https://lifesciencesbc.ca/members/biotecanada-board-announces-addition-of-directors-and-new-chair/ 2021-06-03T21:12:52+00:00 https://lifesciencesbc.ca/members/livanova-completes-initial-closingof-heart-valve-business-to-gyrus-capital/ 2021-06-03T21:38:12+00:00 https://lifesciencesbc.ca/members/corcym-today-the-global-launch/ 2021-06-03T21:57:06+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/corcym.jpg https://lifesciencesbc.ca/ecosystem/dogs-the-new-covid-19-rapid-test/ 2021-06-03T22:06:14+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/sniff.png https://lifesciencesbc.ca/ecosystem/childhood-cancer-discovery-may-stop-tumor-spread-before-it-starts/ 2021-06-03T22:43:21+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/tumordiscovery.jpg https://lifesciencesbc.ca/members/starfish-medical-receives-innovation-award/ 2021-06-07T20:45:41+00:00 https://lifesciencesbc.ca/members/first-responder-survey/ 2021-06-07T21:55:33+00:00 https://lifesciencesbc.ca/ecosystem/fusion-genomics-receives-1-million-award-to-evaluate-novel-genomic-diagnostics-platform-in-collaboration-with-sunnybrook-research-institute/ 2021-06-08T17:36:58+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/FUSION%20GENOMICS.jpg https://lifesciencesbc.ca/members/chinook-therapeutics-to-present-at-the-2021-rbc-capital-markets-global-healthcare-conference/ 2021-06-08T17:40:46+00:00 https://lifesciencesbc.ca/members/chinook-therapeutics-presents-bion-1301-interim-phase-1-2-data-in-patients-with-iga-nephropathy-igan-at-the-58th-era-edta-virtual-congress/ 2021-06-08T17:46:33+00:00 https://lifesciencesbc.ca/members/mesentech-winner-in-2020-bios-startup-stadium/ 2021-06-08T18:04:19+00:00 https://lifesciencesbc.ca/members/26142/ 2021-06-08T18:12:07+00:00 https://lifesciencesbc.ca/ecosystem/fda-grants-accelerated-approval-for-alzheimers-drug/ 2021-06-08T19:01:22+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/fda.jpg https://lifesciencesbc.ca/members/stemcells-chief-innovation-officer-named-to-constellation-researchs-bt150-list/ 2021-06-08T20:18:22+00:00 https://lifesciencesbc.ca/members/stemcell-technologies-is-an-essential-industry-partner-for-covid-19-research-and-vaccine-development/ 2021-06-08T20:19:58+00:00 https://lifesciencesbc.ca/members/virogin-biotech-announces-upcoming-presentation-at-the-aacr-annual-meeting/ 2021-06-08T20:24:04+00:00 https://lifesciencesbc.ca/members/canadas-digital-technology-supercluster-announces-1m-investment-into-healthcare-to-homecare-project-led-by-xco/ 2021-06-08T20:31:36+00:00 https://lifesciencesbc.ca/members/virogin-biotech-announces-abstract-publication-at-the-american-society-of-clinical-oncology-annual-meeting/ 2021-06-08T21:02:50+00:00 https://lifesciencesbc.ca/members/nervgen-pharma-announces-first-subject-dosed-in-phase-1-clinical-trial-of-nvg-291/ 2021-06-08T21:38:23+00:00 https://lifesciencesbc.ca/members/bold-therapeutics-receives-additional-funding-to-support-development-of-bold-100-as-a-novel-antiviral/ 2021-06-09T17:45:41+00:00 https://lifesciencesbc.ca/members/results-from-qu-biologics-crohns-disease-restore-trial-selected-for-oral-presentation-at-ecco-2021/ 2021-06-09T18:12:57+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/Qu-Biologics_logo.png https://lifesciencesbc.ca/members/axolotl-winners-in-douglas-magazine-10-to-watch-awards/ 2021-06-09T19:33:49+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Axolotl-1.jpg https://lifesciencesbc.ca/ecosystem/fraser-health-sets-up-same-day-immunization-clinics-for-people-to-get-first-vaccine-dose/ 2021-06-10T18:48:17+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/global-news.png https://lifesciencesbc.ca/lsbc-news/bio-digital-2021/ 2021-06-11T22:31:24+00:00 https://lifesciencesbc.ca/members/replicel-launches-testing-of-dermal-injector-units/ 2021-06-14T17:37:15+00:00 https://lifesciencesbc.ca/members/replicel-launches-preparations-for-second-skin-rejuvenation-and-tendon-regeneration-clinical-studies/ 2021-06-15T18:00:53+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-increases-cannabinoid-yield-to-5-g-l-with-integrasyn-in-advance-of-commercial-scale-production/ 2021-06-17T19:02:42+00:00 https://lifesciencesbc.ca/members/biotalent-canada-announces-baseline-net-new-requirements-lifted-for-the-student-work-placement-program-swpp/ 2021-06-18T16:19:07+00:00 https://lifesciencesbc.ca/ecosystem/vancouver-researchers-develop-a-quantitative-sars-cov-2-viral-load-test/ 2021-06-18T16:56:58+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/june-17.jpg https://lifesciencesbc.ca/members/response-biomedical-launches-covid-19-sars-cov-2-antigen-test-for-countries-accepting-ce-mark-to-support-the-growing-demand-for-testing/ 2021-06-18T17:18:48+00:00 https://lifesciencesbc.ca/ecosystem/growth-of-vancouver-biotech-companies-sparks-demand-for-specific-real-estate/ 2021-06-18T18:25:00+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/june-18.png https://lifesciencesbc.ca/ecosystem/calling-all-founders-with-massive-ideas-applications-for-cdl-2021-22-program-year-are-still-open/ 2021-06-18T18:55:04+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/CDL.png https://lifesciencesbc.ca/ecosystem/prime-day-deal-amazon-lands-fda-go-ahead-to-sell-covid-19-tests-directly-to-consumers/ 2021-06-18T18:59:40+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/june-18-1.jpg https://lifesciencesbc.ca/members/image-guided-therapeutics-and-diagnostics-symposium/ 2021-06-18T19:16:15+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/Webp.net-resizeimage-50-e1623957834135.jpg https://lifesciencesbc.ca/members/eupraxia-pharmaceuticals-inc-announces-10-million-convertible-debt-agreement-with-silicon-valley-bank-and-conversion-of-6-0-million-pre-ipo-debt/ 2021-06-22T17:53:56+00:00 https://lifesciencesbc.ca/members/qu-biologics-receives-additional-funding-to-accelerate-clinical-development-of-qus-first-in-class-immunotherapeutic-for-covid-19-prevention-and-treatment/ 2021-06-23T16:37:03+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/Qu-Biologics_logo-UcsF1NWGY5rp.png https://lifesciencesbc.ca/members/biotalent-canada-earns-great-place-to-work-accolades-thanks-to-strong-core-values-and-actionable-wellness-strategies/ 2021-06-23T17:20:31+00:00 https://lifesciencesbc.ca/members/sanotize-obtains-health-canada-approval-to-begin-enrolment-for-phase-iii-trials-for-covid-19-anti-viral-treatment/ 2021-06-23T17:41:51+00:00 https://lifesciencesbc.ca/members/sciex-presents-new-accurate-mass-instrument-the-zenotof-7600-system/ 2021-06-23T17:48:00+00:00 https://lifesciencesbc.ca/ecosystem/attend-the-china-biomed-innovation-and-investment-conference-cbiic-2021/ 2021-06-23T23:00:47+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/cbiic.png https://lifesciencesbc.ca/members/take-part-in-biotalents-national-occupational-standards-nos-validation-survey/ 2021-06-24T18:05:45+00:00 https://lifesciencesbc.ca/members/axolotl-receives-innovate-bc-award-through-the-ignite-program/ 2021-06-24T19:04:51+00:00 https://lifesciencesbc.ca/members/first-responder-research/ 2021-06-24T20:38:40+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/EMPOWER.png https://lifesciencesbc.ca/ecosystem/b-c-hires-international-expert-to-apply-new-innovative-thinking-to-long-term-economic-plan/ 2021-06-24T21:31:38+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/png0604n-ravi-kahlon.jpg https://lifesciencesbc.ca/members/call-for-capstone-projects-ubcs-school-of-biomedical-engineering/ 2021-06-25T23:40:28+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/SBME_UBC_Horizontal_Primary_Faculties_Colour.png https://lifesciencesbc.ca/members/inmed-pharmaceuticals-announces-12-million-private-placement-priced-at-the-market-under-nasdaq-rules/ 2021-06-29T17:29:36+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-signs-non-binding-letter-of-intent-to-acquire-baymedica-a-commercial-manufacturer-of-rare-cannabinoids/ 2021-06-29T17:30:31+00:00 https://lifesciencesbc.ca/members/lifelabs-completes-over-2-million-covid-19-molecular-tests/ 2021-06-29T21:12:53+00:00 https://lifesciencesbc.ca/members/lifelabs-partners-with-the-canadian-centre-for-diversity-and-inclusion-ccdi-and-the-globe-and-mail-to-help-amplify-the-voices-of-black-leaders/ 2021-06-29T21:15:14+00:00 https://lifesciencesbc.ca/members/applications-are-open-for-entrepreneurshipubcs-lab2launch-program/ 2021-07-06T21:30:26+00:00 https://lifesciencesbc.ca/members/bold-therapeutics-receives-fda-clearance-to-add-u-s-sites-for-phase-1b-2a-trial-of-bold-100-in-the-treatment-of-advanced-gi-cancers/ 2021-07-07T17:05:14+00:00 https://lifesciencesbc.ca/members/abcellera-responds-to-future-pandemic-threat-with-190m-canadian-facility/ 2021-07-08T21:57:07+00:00 https://lifesciencesbc.ca/members/sanotizes-anti-viral-treatment-made-available-in-israeli-pharmacies/ 2021-07-08T22:48:47+00:00 https://lifesciencesbc.ca/members/incisive-genetics-announces-formation-of-scientific-advisory-board-and-appointment-of-dr-michael-r-hayden-as-chairperson/ 2021-07-08T23:09:55+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/Incisive-Genetics-logo-small.jpg https://lifesciencesbc.ca/members/zymeworks-to-present-at-ladenburg-thalmann-healthcare-conference/ 2021-07-09T17:18:24+00:00 https://lifesciencesbc.ca/lsbc-news/canada-and-uk-foundations-for-innovation-virtual-conference/ 2021-07-12T21:50:56+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/canada-and-uk.png https://lifesciencesbc.ca/members/immunoflex-completes-clinical-study-and-submits-us-and-international-patent-applications/ 2021-07-13T20:51:02+00:00 https://lifesciencesbc.ca/members/qu-biologics-phase-2-restore-trial-data-presented-at-2021-european-crohns-and-colitis-congress/ 2021-07-13T21:34:40+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/Qu-Biologics.png https://lifesciencesbc.ca/members/abcellera-appoints-neil-berkley-as-chief-business-officer/ 2021-07-15T18:14:03+00:00 https://lifesciencesbc.ca/members/incisive-genetics-announces-closing-of-a-2-5-million-seed-investment/ 2021-07-15T18:19:31+00:00 https://lifesciencesbc.ca/members/collaboration-between-abbvie-biogen-and-pfizer-creates-worlds-largest-browsable-resource-linking-rare-protein-coding-genetic-variants-to-human-health-and-disease/ 2021-07-15T18:31:57+00:00 https://lifesciencesbc.ca/members/replicel-applies-for-manufacturing-approval-for-its-collagen-and-tissue-regeneration-cell-therapies/ 2021-07-15T20:51:03+00:00 https://lifesciencesbc.ca/ecosystem/navigating-dscsa-implementation-key-requirements-4-new-fda-guidances/ 2021-07-15T21:09:35+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/industyr-news-july-15.jpg https://lifesciencesbc.ca/members/diverse-pipeline-for-repurposing-drug-company-includes-treatments-for-idiopathic-pulmonary-fibrosis-and-chronic-cough-pancreatic-cancer-and-stroke/ 2021-07-15T21:11:02+00:00 https://lifesciencesbc.ca/members/new-study-aims-to-solve-the-puzzle-of-covid-19s-long-term-impact/ 2021-07-15T21:12:25+00:00 https://lifesciencesbc.ca/members/nervgen-pharma-expands-alzheimers-disease-scientific-advisory-board/ 2021-07-15T21:23:07+00:00 https://lifesciencesbc.ca/members/xco-receives-funding-to-advance-research-and-development-of-edge-computing-ai-technologies-for-chronic-disease-monitoring/ 2021-07-15T23:37:53+00:00 https://lifesciencesbc.ca/members/ico-therapeutics-inc-announces-tsx-venture-exchange-conditional-approval-and-provides-update-regarding-business-combination-with-satellos-bioscience-inc/ 2021-07-16T23:06:45+00:00 https://lifesciencesbc.ca/members/corcym-announces-the-first-patient-enrolled-in-mantra-study/ 2021-07-19T16:59:24+00:00 https://lifesciencesbc.ca/members/replicel-announces-appointment-of-leading-dermatologist-in-japan-as-clinical-advisor/ 2021-07-19T18:54:39+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/Screen-Shot-2021-05-30-at-11.02.29-PM.png https://lifesciencesbc.ca/members/replicel-launches-the-next-stage-of-a-research-project-with-the-university-of-british-columbia-to-build-world-class-hair-follicle-cell-data-map/ 2021-07-19T18:55:49+00:00 https://lifesciencesbc.ca/members/replicel-adds-independent-director/ 2021-07-19T18:57:10+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/Gary-Boddington.png https://lifesciencesbc.ca/members/replicel-announces-record-year-in-patents-granted/ 2021-07-19T18:58:12+00:00 https://lifesciencesbc.ca/members/replicel-announces-appointment-of-leading-sports-medicine-expert-as-orthopedics-clinical-advisor-japan/ 2021-07-19T18:59:01+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/Prof.-Tsukasa-Kumai-Image.jpg https://lifesciencesbc.ca/members/replicel-closes-second-tranche-of-strategic-investment-commitment/ 2021-07-19T18:59:58+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/RepliCel-Mainpoint-Logo.jpg https://lifesciencesbc.ca/members/replicel-closes-first-tranche-of-strategic-investment-commitment/ 2021-07-19T19:00:44+00:00 https://lifesciencesbc.ca/members/eupraxia-pharmaceuticals-inc-announces-authorization-of-clinical-trial-application-for-phase-2-trial-of-ep-104iar-in-osteoarthritis-of-the-knee/ 2021-07-19T19:02:48+00:00 https://lifesciencesbc.ca/members/aurina-to-present-supportive-aurora-2-continuation-study-interim-analysis-demonstrating-long-term-safety-efficacy-of-lupkynis-volclosporin-in-subjects-with-lupus-nephritis/ 2021-07-20T00:23:21+00:00 https://lifesciencesbc.ca/members/aurina-pharmaceuticals-to-present-at-the-jefferies-virtual-healthcare-conference/ 2021-07-20T00:23:29+00:00 https://lifesciencesbc.ca/members/picoquants-business-trip-to-vancouver/ 2021-07-22T17:52:50+00:00 https://lifesciencesbc.ca/members/xco-receives-funding-to-advance-research-and-development-of-edge-computing-ai-technologies-for-chronic-disease-monitoring-2/ 2021-07-22T20:26:43+00:00 https://lifesciencesbc.ca/members/axolotl-biosciences-ceo-dr-stephanie-willerth-features-on-podcast-with-medtalkcracy/ 2021-07-22T20:35:18+00:00 https://lifesciencesbc.ca/members/symvivo-corporation-receives-4-6m-support-for-oral-covid-19-vaccine/ 2021-07-22T20:42:12+00:00 https://lifesciencesbc.ca/members/vgh-ubc-hospital-foundation-welcomes-two-new-board-members/ 2021-07-22T20:53:42+00:00 https://lifesciencesbc.ca/members/ico-therapeutics-inc-announces-tsx-venture-exchange-conditional-approval-and-provides-update-regarding-business-combination-with-satellos-bioscience-inc-2/ 2021-07-22T21:18:06+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/ICO-THERAPEUTICS-300x200.png https://lifesciencesbc.ca/members/pfizer-and-biontech-annouce-collaboratioin-with-biovac-to-manufacture-and-distribute-covid-19-vaccine-doses-within-africa/ 2021-07-22T21:29:05+00:00 https://lifesciencesbc.ca/ecosystem/government-of-canada-announces-support-for-university-of-victoria-to-create-centre-for-advanced-materials-related-technology-camtec-biomedical-core/ 2021-07-22T21:39:28+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/uvic-support.jpg https://lifesciencesbc.ca/members/life-sciences-baltics-2021-is-approaching/ 2021-07-26T20:09:53+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/Life-Sciences-Baltics.png https://lifesciencesbc.ca/members/abcelleras-founding-ceo-carl-hansen-wins-one-of-seven-ey-entrepreneur-of-the-year-2021-pacific/ 2021-07-29T21:44:49+00:00 https://lifesciencesbc.ca/members/acuitas-therapeutics-names-new-director-of-chemistry/ 2021-07-29T21:49:34+00:00 https://lifesciencesbc.ca/members/lumira-ventures-closes-on-us255-million-of-new-capital-to-build-transformative-healthcare-companies/ 2021-07-29T21:51:23+00:00 https://lifesciencesbc.ca/members/entrepreneurshipubcs-lab2launch-venture-building-program-is-open-for-applications-until-august-3rd/ 2021-07-29T21:53:01+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/entrepreneurship@UBC.jpg https://lifesciencesbc.ca/members/imc-supports-national-biomanufacturing-and-life-sciences-strategy-commitment-to-ensuring-best-in-class-regulation/ 2021-07-29T21:55:17+00:00 https://lifesciencesbc.ca/members/biotecanada-supports-government-of-canadas-biomanufacturing-strategy/ 2021-07-29T22:02:40+00:00 https://lifesciencesbc.ca/members/zucara-therapeutics-doses-first-patients-in-phase-1b-trial-of-zt-01/ 2021-07-29T22:08:42+00:00 https://lifesciencesbc.ca/ecosystem/bc-steps-up-measures-to-increase-vaccinations-with-vax-for-bc-campaign/ 2021-07-29T22:23:48+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/vax-for-bc.jpg https://lifesciencesbc.ca/ecosystem/perfume-ingredient-offers-hope-for-parkinsons-disease/ 2021-07-29T22:25:17+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/parkinson.jpg https://lifesciencesbc.ca/members/sanotizes-covid-busting-hand-sanitizer-for-the-nose-goes-on-sale-in-israel/ 2021-07-29T22:28:49+00:00 https://lifesciencesbc.ca/members/eqrx-and-abcellera-announce-collaboration-to-accelerate-the-advancement-of-new-innovative-medicines/ 2021-08-05T16:36:50+00:00 https://lifesciencesbc.ca/members/immunoprecise-welcomes-vice-president-of-client-relations-and-vice-president-of-marketing-to-its-leadership-team-accelerating-its-growth-and-expansion-plans/ 2021-08-05T16:57:47+00:00 https://lifesciencesbc.ca/ecosystem/government-extends-pandemic-recovery-programs-and-business-supports/ 2021-08-05T17:35:56+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/08/deputy-aug-5.png https://lifesciencesbc.ca/ecosystem/b-c-s-highest-honour-recognizes-16-british-columbians/ 2021-08-05T17:47:48+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/08/orderofbc.jpg https://lifesciencesbc.ca/members/tachyon-and-abcellera-collaborate-to-develop-novel-antibody-therapeutic-targeting-tgf-%ce%b2-superfamily-member-for-the-treatment-of-cancer/ 2021-08-05T18:35:31+00:00 https://lifesciencesbc.ca/members/zymeworks-announces-milestone-payment-as-janssen-achieves-first-patient-dosed-for-its-bispecific-antibody-utilizing-zymeworks-azymetric-and-efect-therapeutic-platforms/ 2021-08-05T18:44:57+00:00 https://lifesciencesbc.ca/members/ico-therapeutics-inc-announces-shareholder-approval-of-business-combination-with-satellos-bioscience-inc/ 2021-08-06T23:14:42+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/ICO-THERAPEUTICS-300x200.png https://lifesciencesbc.ca/members/health-canada-approves-arazlo-tazarotene-lotion-0-045-first-such-lotion-treatment-for-acne-vulgaris/ 2021-08-09T16:15:31+00:00 https://lifesciencesbc.ca/ecosystem/canada-will-be-ready-modernas-plans-to-build-mrna-vaccine-plant-to-help-country-brace-for-future-outbreaks-big-or-small-ceo-says/ 2021-08-11T20:01:56+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/08/aug-11.jpeg https://lifesciencesbc.ca/members/stressmarq-invites-you-the-9th-annual-neuroscience-virtual-conference/ 2021-08-12T16:25:38+00:00 https://lifesciencesbc.ca/members/algernon-pharmaceuticals-announces-exclusive-licensing-agreement-with-dartmouth-college/ 2021-08-12T16:30:08+00:00 https://lifesciencesbc.ca/members/genome-bc-announces-new-chief-scientific-officer-vp-sectors/ 2021-08-12T16:31:43+00:00 https://lifesciencesbc.ca/members/life-sciences-bc-names-novateur-ventures-strategic-partner-of-the-year/ 2021-08-12T16:52:03+00:00 https://lifesciencesbc.ca/ecosystem/minister-ng-announces-a-joint-statement-committing-to-a-federal-provincial-partnership-with-b-c-to-advance-an-integrated-cleantech-market/ 2021-08-12T17:28:23+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/08/isedc.jpg https://lifesciencesbc.ca/ecosystem/burnaby-biotech-ditches-needles-for-pills-in-covid-19-fight/ 2021-08-12T17:32:06+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/08/symvivo-cc.jpg https://lifesciencesbc.ca/ecosystem/trade-accelerator-program-for-women-led-businesses/ 2021-08-12T17:39:23+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/08/tap-women.jpg https://lifesciencesbc.ca/members/precision-nanosystems-sets-time-and-place-to-open-new-genetic-medicine-gmp-biomanufacturing-centre-in-vancouver-bc/ 2021-08-12T18:19:31+00:00 https://lifesciencesbc.ca/members/pfizer-authorizes-1-billion-for-oral-covid-19-treatment-ceo-says/ 2021-08-17T16:57:53+00:00 https://lifesciencesbc.ca/ecosystem/province-invests-in-post-secondary-research-innovation-for-a-stronger-b-c/ 2021-08-17T17:35:17+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/BC-government-logo.png https://lifesciencesbc.ca/members/aurinia-acquires-novel-pipeline-assets-targeting-autoimmune-and-kidney-related-diseases/ 2021-08-17T17:52:16+00:00 https://lifesciencesbc.ca/ecosystem/sweet-pharma-days-2nd-edition-call-for-startup-proposals-now-open/ 2021-08-17T18:22:48+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/08/sweet-pharma-day.png https://lifesciencesbc.ca/members/stemcell-technologies-and-hubrecht-organoid-technology-to-partner-on-non-oncology-organoid-drug-screening-services/ 2021-08-18T21:15:03+00:00 https://lifesciencesbc.ca/members/aequus-and-revision-to-collaborate-on-stargardt-disease-program/ 2021-08-18T21:22:46+00:00 https://lifesciencesbc.ca/members/nervgen-pharma-provides-an-operational-update-on-its-ongoing-phase-1-clinical-trial-and-reports-second-quarter-2021-results/ 2021-08-19T18:09:25+00:00 https://lifesciencesbc.ca/members/new-fellowship-in-health-systems-resilience-opens-call-for-applicants/ 2021-08-19T21:17:06+00:00 https://lifesciencesbc.ca/members/genevant-sciences-announces-global-collaboration-and-license-agreement-with-takeda-to-develop-novel-nonviral-gene-therapies-for-up-to-two-rare-liver-diseases/ 2021-08-23T17:08:12+00:00 https://lifesciencesbc.ca/members/pfizer-to-acquire-trillium-therapeutics-inc/ 2021-08-23T17:09:31+00:00 https://lifesciencesbc.ca/members/xenon-pharmaceuticals-strengthens-leadership-team-with-appointment-of-dr-christopher-kenney-as-chief-medical-officer/ 2021-08-23T17:11:15+00:00 https://lifesciencesbc.ca/ecosystem/register-to-pharmaceutical-sciences-groups-events/ 2021-08-26T17:45:43+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/08/psg.png https://lifesciencesbc.ca/members/take-part-in-biotalents-national-occupational-standards-nos/ 2021-08-26T20:59:58+00:00 https://lifesciencesbc.ca/members/novartis-canada-launches-the-biome-summit-a-catalyst-to-healthcare-transformation-and-the-future-of-care-systems-in-canada/ 2021-08-30T16:58:09+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/08/novartis.png https://lifesciencesbc.ca/members/biotalent-canada-named-to-the-2021-list-of-best-workplaces-for-giving-back/ 2021-08-30T20:38:28+00:00 https://lifesciencesbc.ca/members/gemina-labs-announces-research-and-development-appointments/ 2021-08-30T22:52:12+00:00 https://lifesciencesbc.ca/members/latest-overview-of-the-life-sciences-ecosystem-in-lithuania-released/ 2021-08-31T17:18:01+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/08/Life-Sciences-LT.PNG https://lifesciencesbc.ca/members/alpha-9-theranostics-announces-11-million-series-a-financing-to-advance-portfolio-of-radiotherapeutics-and-diagnostics/ 2021-08-31T21:53:22+00:00 https://lifesciencesbc.ca/ecosystem/new-study-examines-achilles-heel-of-cancer-tumours-paving-the-way-for-new-treatment-strategies/ 2021-09-01T21:36:55+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/08/UBC-logo.jpg https://lifesciencesbc.ca/ecosystem/ubcs-annual-address-powering-bio-innovation-in-british-columbia/ 2021-09-02T18:31:27+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/09/gv-board-of-trade-e1630607437424.png https://lifesciencesbc.ca/members/stemcell-technologies-launches-human-pluripotent-stem-cell-characterization-and-banking-services-in-partnership-with-wicell/ 2021-09-02T18:46:24+00:00 https://lifesciencesbc.ca/members/entrepreneurshipubc-immersion-week-2021/ 2021-09-02T18:55:06+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/09/Screen-Shot-2021-09-01-at-12.17.19-PM.png https://lifesciencesbc.ca/members/biotecanada-invites-you-to-meet-bionation/ 2021-09-02T21:00:30+00:00 https://lifesciencesbc.ca/ecosystem/apply-to-the-socal-biotech-highway-program-2021-22/ 2021-09-03T20:20:41+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/08/government-of-can-e1630700415257.png https://lifesciencesbc.ca/ecosystem/the-government-of-canada-announces-biomanufacturing-and-life-sciences-strategy/ 2021-09-03T20:25:19+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/08/government-of-can-e1630700415257.png https://lifesciencesbc.ca/ecosystem/jobs-and-growth-fund-in-western-canada-is-now-open-for-applications/ 2021-09-03T20:27:12+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/08/government-of-can-e1630700415257.png https://lifesciencesbc.ca/ecosystem/apply-to-the-canadian-technology-accelerator-san-francisco-health/ 2021-09-03T20:32:19+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/Untitled-design-2-e1630701118959.png https://lifesciencesbc.ca/ecosystem/additional-funding-for-business-recovery-grant-to-benefit-thousands-of-businesses/ 2021-09-03T20:34:35+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/more-funding-e1630701252162.jpg https://lifesciencesbc.ca/lsbc-news/life-sciences-bc-announces-annual-award-winners/ 2021-09-07T20:44:20+00:00 https://lifesciencesbc.ca/lsbc-news/wendy-hurlburt-invited-as-industry-panel-speaker-for-ubcs-sbme-annual-symposium/ 2021-09-07T21:01:36+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/UBC-SBME-Virtual-Symposium-Event-Banner.png https://lifesciencesbc.ca/lsbc-news/lsbc-ceo-wendy-hurlburt-presents-for-the-vantec-angel-conference/ 2021-09-07T21:04:27+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/VANTEC-Screeenshot-Investor-meeting.png https://lifesciencesbc.ca/lsbc-news/lsbc-invited-for-the-2021-med-tech-panel-for-euccan/ 2021-09-07T21:12:14+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/05/Eu-tech.jpg https://lifesciencesbc.ca/lsbc-news/lsbc-features-in-news1130-article-summit-in-vancouver-drawing-global-attention-to-bc-companies-helping-develop-covid-19-vaccine/ 2021-09-07T21:44:17+00:00 https://lifesciencesbc.ca/lsbc-news/lsbc-ceo-wendy-hurlburt-featured-in-sfus-best-of-the-wwest-podcast/ 2021-09-07T21:47:09+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/WWEST.png https://lifesciencesbc.ca/lsbc-news/26831/ 2021-09-07T22:09:09+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/conversation-that-matter.jpg https://lifesciencesbc.ca/members/carl-hansen-phd-founder-and-ceo-of-abcellera-receives-2021-bloom-burton-award/ 2021-09-08T17:33:48+00:00 https://lifesciencesbc.ca/members/novartis-to-host-the-first-virtual-biome-summit-on-cvd/ 2021-09-08T19:45:14+00:00 https://lifesciencesbc.ca/members/izotropic-nominated-for-best-new-radiology-device-award/ 2021-09-09T19:18:35+00:00 https://lifesciencesbc.ca/members/izotropic-receives-notice-of-allowance-for-new-3d-x-ray-beam-filter-patent-from-uspto/ 2021-09-09T19:30:16+00:00 https://lifesciencesbc.ca/ecosystem/application-socal-tech-highway-telehealth-program-2021-22/ 2021-09-10T16:51:17+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/09/government-of-can-e1630700321799.png https://lifesciencesbc.ca/members/inmed-pharmaceuticals-signs-definitive-agreement-to-acquire-baymedica-a-leading-commercial-manufacturer-of-rare-cannabinoids/ 2021-09-13T16:25:35+00:00 https://lifesciencesbc.ca/members/abcellera-acquires-tetragenetics-enhancing-capabilities-to-generate-antibodies-against-high-value-targets/ 2021-09-13T16:34:10+00:00 https://lifesciencesbc.ca/lsbc-news/lsbc-ceo-wendy-hurlburt-takes-part-in-resilient-healthcare-coalition/ 2021-09-13T20:47:06+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/RHC-June-Creative-4-e1631047817296.png https://lifesciencesbc.ca/members/from-medical-device-start-up-to-ipo-webinar/ 2021-09-14T16:53:04+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/09/Untitled-design-15-e1631638184702.png https://lifesciencesbc.ca/members/innovate-bc-announces-raghwa-gopal-as-new-president-and-ceo/ 2021-09-14T17:28:28+00:00 https://lifesciencesbc.ca/members/takedas-global-acquisition-of-shire-creates-an-expanded-takeda-canada-to-bring-better-health-and-a-brighter-future-to-canadians/ 2021-09-14T17:30:27+00:00 https://lifesciencesbc.ca/members/ubc-appoints-robin-ciceri-as-the-new-vice-president-external-relations/ 2021-09-14T17:32:02+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-receives-nasdaq-listing-extension/ 2021-09-14T17:35:44+00:00 https://lifesciencesbc.ca/members/genome-bc-appoints-new-executive-director-corporate-development/ 2021-09-14T17:39:50+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-achieves-halfway-enrollment-point-for-phase-2-clinical-trial-of-val-083-in-newly-diagnosed-mgmt-unmethylated-gbm/ 2021-09-14T17:42:02+00:00 https://lifesciencesbc.ca/members/genxys-health-care-systems-announces-completion-of-oversubscribed-seed-round-financing-to-launch-leading-precision-prescribing-software-into-the-us-market/ 2021-09-14T17:43:44+00:00 https://lifesciencesbc.ca/members/nztech-announces-sale-of-tipso-image-navigation-systems-to-the-hospital-for-sick-children/ 2021-09-14T17:47:20+00:00 https://lifesciencesbc.ca/members/arbutus-to-present-at-cowen-health-care-conference/ 2021-09-14T17:48:58+00:00 https://lifesciencesbc.ca/members/arbutus-to-report-fourth-quarter-and-year-end-2018-financial-results-and-provide-corporate-update/ 2021-09-14T17:52:08+00:00 https://lifesciencesbc.ca/members/2019-lifesciences-bc-annual-award-winners-announced/ 2021-09-14T17:57:57+00:00 https://lifesciencesbc.ca/members/phoenix-molecular-designs-to-present-at-biocoms-2019-global-life-science-partnering-conference/ 2021-09-14T18:00:28+00:00 https://lifesciencesbc.ca/members/phoenix-molecular-designs-appoints-magda-marquet-ph-d-to-its-board-of-directors/ 2021-09-14T18:14:31+00:00 https://lifesciencesbc.ca/members/triumf-receives-historic-investment-in-2019-federal-budget/ 2021-09-14T18:30:54+00:00 https://lifesciencesbc.ca/members/new-scientific-study-finds-stevia-sweeteners-have-no-impact-on-digestive-system-bacteria/ 2021-09-14T18:34:48+00:00 https://lifesciencesbc.ca/members/onestep-laboratories-to-develop-a-stable-formula-for-chlorine-analysis/ 2021-09-14T18:36:56+00:00 https://lifesciencesbc.ca/members/delmar-pharmaceuticals-receives-approval-from-md-anderson-cancer-centers-irb-for-protocol-expansion-to-include-maintenance-stage-mgmt-unmethylated-gbm-patients-in-ongoing-phase-2-trial-of-val-083/ 2021-09-14T18:38:25+00:00 https://lifesciencesbc.ca/members/wat-medical-receives-interview-from-nhk-japans-national-broadcasting-organization/ 2021-09-14T20:23:16+00:00 https://lifesciencesbc.ca/lsbc-news/lsbc-ceo-wendy-hurlburt-featured-in-biv-podcast-how-covid-19-is-challenging-the-life-sciences-sector/ 2021-09-15T16:47:31+00:00 https://lifesciencesbc.ca/members/eupraxia-pharmaceuticals-inc-commences-patient-screening-for-its-phase-2-trial-for-osteoarthritis-drug-candidate-ep-104iar/ 2021-09-15T17:59:08+00:00 https://lifesciencesbc.ca/members/life-sciences-sme-market-access-program/ 2021-09-15T18:34:01+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/09/institute-of-health-economics-2-e1631214615798.png https://lifesciencesbc.ca/members/inmed-pharmaceuticals-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference/ 2021-09-15T22:33:44+00:00 https://lifesciencesbc.ca/members/replicel-and-university-of-victoria-collaboration-leads-to-bioengineering-innovations-funding-and-patents/ 2021-09-16T16:50:07+00:00 https://lifesciencesbc.ca/members/one-patient-one-team-approach-for-hospitals-thanks-to-barco-steered-project-partner/ 2021-09-16T17:02:19+00:00 https://lifesciencesbc.ca/members/eupraxia-pharmaceuticals-inc-provides-update-for-phase-2-osteoarthritis-drug-candidate-ep-104iar/ 2021-09-17T16:06:48+00:00 https://lifesciencesbc.ca/members/bold-100-exhibits-potent-anti-tumor-activity-in-validated-i-o-in-vivo-models/ 2021-09-17T17:56:47+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-to-report-full-year-fiscal-2021-financial-results-and-business-update-on-september-24-2021/ 2021-09-17T20:46:12+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-and-baymedica-participating-in-tribe-publics-webinar-accelerating-the-commercialization-of-rare-cannabinoids/ 2021-09-17T20:47:26+00:00 https://lifesciencesbc.ca/members/st-pauls-foundation-welcomes-nicole-coleman-and-karimah-es-sabbar-to-board-of-directors/ 2021-09-21T16:29:33+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/st-paul.jpg https://lifesciencesbc.ca/members/izotropic-signs-agreement-with-johns-hopkins-university-school-of-medicine-to-develop-deep-machine-learning-algorithms-for-izoview-breast-ct/ 2021-09-21T22:18:05+00:00 https://lifesciencesbc.ca/members/lilly-to-supply-the-eu-and-eea-with-up-to-220000-doses-of-abcellera-discovered-bamlanivimab-together-with-etesevimab-for-the-treatment-of-confirmed-covid-19/ 2021-09-22T18:03:20+00:00 https://lifesciencesbc.ca/members/preventing-covid-19-with-photodisinfection-new-results-presented-at-european-society-of-photobiology/ 2021-09-23T17:30:31+00:00 https://lifesciencesbc.ca/members/student-work-placement-program/ 2021-09-23T23:38:19+00:00 https://lifesciencesbc.ca/members/acuitas-therapeutics-received-global-impact-award-from-life-sciences-bc/ 2021-09-24T16:44:40+00:00 https://lifesciencesbc.ca/members/xuanzhu-and-signalchem-lifesciences-corporation-announce-collaboration-and-licensing-agreement-for-slc-391-in-the-greater-china-region/ 2021-09-27T16:01:15+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/09/signalchem-e1632758420308.png https://lifesciencesbc.ca/members/canadas-prime-minister-justin-trudeau-announced-today-precision-nanosystems-will-receive-18-2-million-from-the-government-of-canada-to-develop-an-rna-vaccine-for-covid-19/ 2021-09-27T20:55:14+00:00 https://lifesciencesbc.ca/ecosystem/digital-technology-superclusters-digital-demo-day/ 2021-09-27T21:02:06+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/Digital-Demo-Day-e1619228179422.png https://lifesciencesbc.ca/members/molecular-you-named-a-2019-gartner-cool-vendor-in-healthcare-artificial-intelligence/ 2021-09-27T21:05:04+00:00 https://lifesciencesbc.ca/members/molecular-forecaster-continues-quest-to-fast-track-drug-discovery-with-two-new-public-private-partnerships/ 2021-09-28T16:59:42+00:00 https://lifesciencesbc.ca/members/nervgen-pharma-partners-with-imeka-to-use-novel-neuroimaging-technology-in-clinical-trials/ 2021-09-28T18:17:32+00:00 https://lifesciencesbc.ca/members/satisfai-health-acquires-global-license-for-ai-software-to-detect-early-cancer-in-barretts-esophagus/ 2021-09-28T18:31:14+00:00 https://lifesciencesbc.ca/members/grantek-names-4ir-solutions-a-strategic-partner/ 2021-09-28T18:50:44+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/09/grantek-e1632855028936.png https://lifesciencesbc.ca/members/hello-world-www-herstasis-com-is-live/ 2021-09-29T22:26:13+00:00 https://lifesciencesbc.ca/members/bold-therapeutics-is-pleased-to-be-featured-in-insights-magazines-fall-issue/ 2021-09-29T22:44:51+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-announces-commencement-of-phase-2-clinical-trial-investigating-cannabinol-cbn-a-rare-cannabinoid-in-the-treatment-of-epidermolysis-bullosa/ 2021-10-01T16:13:36+00:00 https://lifesciencesbc.ca/members/gsk-announces-purchase-agreement-with-the-government-of-canada-for-covid-19-monoclonal-antibody-therapy-sotrovimab/ 2021-10-04T21:03:45+00:00 https://lifesciencesbc.ca/members/28966/ 2021-10-04T21:46:37+00:00 https://lifesciencesbc.ca/members/xenon-pharmaceuticals-announces-positive-topline-results-from-phase-2b-x-tole-clinical-trial-of-xen1101-for-the-treatment-of-focal-epilepsy/ 2021-10-05T23:15:36+00:00 https://lifesciencesbc.ca/members/lifesciences-bc-attracts-international-audience-for-annual-investors-summit/ 2021-10-06T15:55:33+00:00 https://lifesciencesbc.ca/members/the-novel-discovery-by-the-university-of-british-columbia-and-signalchem-lifesciences-corporation-has-been-published-by-the-prestigious-journal-blood/ 2021-10-06T16:00:44+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/Signal-Chem-Lifesciences.jpg https://lifesciencesbc.ca/members/collplant-to-supply-rhcollagen-to-stemcell-technologies-for-use-in-a-broad-range-of-cell-culture-applications/ 2021-10-06T18:55:26+00:00 https://lifesciencesbc.ca/members/johnson-johnson-initiates-pivotal-global-phase-3-clinical-trial-of-janssens-covid-19-vaccine-candidate/ 2021-10-06T18:56:50+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/Janssen_3c_RGB_cropped-300x151.jpg https://lifesciencesbc.ca/members/molecular-you-signs-agreement-for-roche-to-use-its-molecular-profiling-technology/ 2021-10-06T18:58:29+00:00 https://lifesciencesbc.ca/members/green-economy-to-receive-big-talent-boost-from-3-7m-wage-subsidy-program/ 2021-10-06T19:01:20+00:00 https://lifesciencesbc.ca/members/zymeworks-expands-commercial-team-and-creates-new-rd-role/ 2021-10-06T19:04:20+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/02/Zymeworks-Logo_color-300x107.png https://lifesciencesbc.ca/members/zymeworks-to-participate-in-upcoming-investor-conferences-and-events/ 2021-10-06T19:04:52+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/02/Zymeworks-Logo_color-300x107.png https://lifesciencesbc.ca/members/pr-associates-announces-media-training-workshops-focused-on-lifescience-and-biotech-industry/ 2021-10-06T19:06:20+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/03/PR-Associates-Logo-small-1-150x92.png https://lifesciencesbc.ca/members/psychedelic-medicine-start-up-clairvoyant-therapeutics-welcomes-biotech-cannabis-veteran-greg-engel-as-director-names-long-trinh-as-cfo/ 2021-10-06T22:47:52+00:00 https://lifesciencesbc.ca/members/xenon-pharmaceuticals-announces-proposed-public-offering/ 2021-10-07T22:11:04+00:00 https://lifesciencesbc.ca/members/replicel-life-sciences-appoints-one-of-japans-foremost-regenerative-medicine-industry-business-leaders-as-strategic-advisor/ 2021-10-13T16:45:02+00:00 https://lifesciencesbc.ca/members/izotropic-reaches-q3-milestones-and-provides-engineering-update/ 2021-10-13T16:47:28+00:00 https://lifesciencesbc.ca/members/universities-and-the-provincial-economy/ 2021-10-13T17:30:49+00:00 https://lifesciencesbc.ca/members/data-up-to-8-years-for-roches-ocrevus-ocrelizumab-show-early-and-ongoing-treatment-significantly-reduced-risk-of-requiring-a-walking-aid-in-relapsing-multiple-sclerosis-and-disability-progr/ 2021-10-13T22:11:20+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-completes-acquisition-of-baymedica-creating-a-market-leader-in-the-manufacturing-of-rare-cannabinoids/ 2021-10-13T22:15:50+00:00 https://lifesciencesbc.ca/members/new-study-will-examine-the-resiliency-of-canadas-bio-economy-to-plan-the-industrys-future/ 2021-10-14T17:17:16+00:00 https://lifesciencesbc.ca/members/michael-smith-foundation-for-health-research-and-the-bc-academic-health-science-network-unite-to-drive-discovery-and-innovation-in-bcs-vibrant-health-research-system/ 2021-10-14T18:55:33+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/Michael-Smith-white-background-e1634237682410.png https://lifesciencesbc.ca/members/canadas-bio-economy-facing-severe-labour-shortage/ 2021-10-14T23:31:28+00:00 https://lifesciencesbc.ca/members/the-creator-economy-how-it-is-affecting-health-and-wellness-providers/ 2021-10-15T00:02:53+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/The-Creator-Economy-Health-and-Wellness-Providers-303-x-194-px.png https://lifesciencesbc.ca/members/positive-signals-for-endoscopic-and-histologic-response-in-patients-with-crohns-disease-treated-with-qu-biologics-qbeco/ 2021-10-19T18:46:31+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/12/Qu-Biologics_logo-300x101.png https://lifesciencesbc.ca/members/ico-therapeutics-announces-joint-development-of-ico-019-with-skymount-medical/ 2021-10-19T18:47:55+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/07/ICO-THERAPEUTICS-300x200.png https://lifesciencesbc.ca/members/kintara-therapeutics-to-present-at-the-h-c-wainwright-bioconnect-2021-virtual-conference/ 2021-10-19T18:48:40+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/09/kintara-logo-300x83.png https://lifesciencesbc.ca/members/generator-11-0-competition-call-for-applications-apply-by-feb-5th-2021/ 2021-10-19T18:50:07+00:00 https://lifesciencesbc.ca/wp-content/uploads/2015/06/discovery_parks1.jpg https://lifesciencesbc.ca/members/inmed-to-participate-at-virtual-conferences-in-january-2021/ 2021-10-19T18:50:54+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/symvivo-announcing-research-collaboration-with-merck/ 2021-10-19T18:52:28+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/03/5cedd55651a2b24ba2593ad6_Symvivo-Logo-p-1600-300x62.png https://lifesciencesbc.ca/members/neoleukin-therapeutics-to-present-at-j-p-morgan-healthcare-conference/ 2021-10-19T18:53:16+00:00 https://lifesciencesbc.ca/members/bold-therapeutics-secures-funding-to-prepare-bold-100-for-covid-19-clinical-trials/ 2021-10-19T18:54:15+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/100-300x157.jpg https://lifesciencesbc.ca/members/global-coalition-for-adaptive-research-kazia-and-kintara-announce-commencement-of-kazias-paxalisib-and-kintaras-val-083-in-gbm-agile-trial/ 2021-10-19T19:01:07+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/09/kintara-logo-300x83.png https://lifesciencesbc.ca/members/sonic-incytes-introduces-velacurtm-at-2021-digital-medicine-medtech-showcase/ 2021-10-19T19:02:41+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/01/Sonic-Incytes_Primary_Colour-002-300x52.png https://lifesciencesbc.ca/members/aurinia-pharmaceuticals-to-present-at-two-upcoming-virtual-healthcare-conferences/ 2021-10-19T19:05:21+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/10/Aurinia-Pharmaceuticals-300x117.png https://lifesciencesbc.ca/members/neoleukin-therapeutics-receives-clinical-hold-letter-from-u-s-fda-related-to-cmc-assay-development-for-nl-201/ 2021-10-19T19:06:02+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/neoleukin-logo-stacked-fullcolor-square-rgb-300x300.jpg https://lifesciencesbc.ca/members/inmed-announces-results-of-second-phase-1-clinical-trial-of-inm-755-cbn-cream-in-healthy-subjects/ 2021-10-19T19:09:37+00:00 https://lifesciencesbc.ca/wp-content/uploads/2018/02/inmed.jpg https://lifesciencesbc.ca/members/abcellera-biologicss-billionaire-boss-planning-hiring-spree-in-vancouver-hometown-after-record-setting-ipo/ 2021-10-19T19:11:33+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/08/AbCellera_Full-Colour_RGB_1-300x212.png https://lifesciencesbc.ca/members/covid-busting-nasal-spray-begins-uk-trials-january-11th/ 2021-10-19T19:12:35+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Sanotize.jpg https://lifesciencesbc.ca/members/5n-plus-acquires-stake-in-microbion-and-secures-drug-substance-manufacturing-rights/ 2021-10-19T19:16:20+00:00 https://lifesciencesbc.ca/members/silicon-valley-bank-healthcare-investments-exits-2021-annual-report/ 2021-10-19T19:16:57+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/10/Main-logo-SVB-300x177.jpg https://lifesciencesbc.ca/members/kintara-announces-initiation-of-patient-recruitment-for-val-083s-study-arm-in-the-gbm-agile-trial/ 2021-10-19T19:17:35+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/09/kintara-logo-300x83.png https://lifesciencesbc.ca/members/new-imc-report-shows-impact-of-chronic-disease-and-increased-claims-on-private-drug-plans/ 2021-10-19T19:19:13+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/09/Innovative-medicines-canada-300x124.png https://lifesciencesbc.ca/members/biotecanada-is-pleased-to-announce-the-launch-of-bioech-connec/ 2021-10-19T19:21:37+00:00 https://lifesciencesbc.ca/members/nervgen-presents-interim-phase-1-clinical-trial-data-for-nvg-291-at-the-american-neurological-association-146th-annual-meeting-nvg-291-demonstrated-to-be-well-tolerated-along-with-a-favorable-pharma/ 2021-10-19T21:15:13+00:00 https://lifesciencesbc.ca/members/msfhrs-2021-suite-of-funding-opportunities-will-enable-innovative-health-research-across-bc/ 2021-10-20T22:29:58+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/10/MSFHR-logo-new-e1583192530215.jpg https://lifesciencesbc.ca/members/entrepreneurshipubcs-core-and-l2l-recruitment-hiring-in-the-us-event-coming-up/ 2021-10-20T22:30:47+00:00 https://lifesciencesbc.ca/wp-content/uploads/2019/10/entrepreneurship-ubc-logo-300x106.png https://lifesciencesbc.ca/members/immunoflex-receives-flex-10-product-approval-from-health-canada/ 2021-10-20T22:31:33+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/09/immunoflex-300x51.png https://lifesciencesbc.ca/members/testing-stream-open-calls-for-innovative-prototypes/ 2021-10-20T22:35:53+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/01/Government-of-Canada-Logo-300x92.png https://lifesciencesbc.ca/members/inmed-pharmaceuticals-to-participate-in-2021-cannabinoid-derived-pharmaceuticals-industry-review-summit-europe/ 2021-10-20T22:38:22+00:00 https://lifesciencesbc.ca/members/choosing-the-right-translational-oncology-indication/ 2021-10-26T17:28:32+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/Untitled-design-28.png https://lifesciencesbc.ca/wp-content/uploads/2021/10/preview_1633124755-0-303x194.png https://lifesciencesbc.ca/members/spinafx-and-starfish-medical-enter-into-a-strategic-commercialization-contract-manufacturing-agreement/ 2021-10-27T16:33:43+00:00 https://lifesciencesbc.ca/members/algernon-pharmaceuticals-announces-receipt-of-cad2m-cash-refund-from-australian-research-program-and-files-application-to-list-its-common-shares-on-nasdaq-capital-market/ 2021-10-27T19:44:50+00:00 https://lifesciencesbc.ca/members/lumira-ventures-announces-first-investment-from-the-angellini-lumira-biosciences-fund-in-genep/ 2021-10-27T20:14:48+00:00 https://lifesciencesbc.ca/members/ken-frazier-named-chief-executives-2021-ceo-of-the-year/ 2021-10-27T20:38:54+00:00 https://lifesciencesbc.ca/members/nervgen-pharma-announces-spinal-cord-injury-clinical-advisory-board/ 2021-10-27T20:45:13+00:00 https://lifesciencesbc.ca/members/boehringer-ingelheim-opens-high-tech-tablet-production-facility-in-ingelheim/ 2021-10-27T20:50:41+00:00 https://lifesciencesbc.ca/members/health-research-foundation-announces-recipient-of-its-new-fellowship-in-health-systems-resilience/ 2021-10-28T18:29:03+00:00 https://lifesciencesbc.ca/members/evonik-acquires-sustainable-botanicals-pioneer-botanica-as-the-next-step-towards-leading-the-active-cosmetic-ingredients-market/ 2021-10-28T18:37:04+00:00 https://lifesciencesbc.ca/members/replicel-announces-dermaprecise-trademark-for-dermal-injector-product-line/ 2021-10-28T20:19:20+00:00 https://lifesciencesbc.ca/members/abbvie-highlights-innovative-research-from-its-rheumatology-portfolio-at-acr-convergence-2021/ 2021-11-01T17:44:37+00:00 https://lifesciencesbc.ca/members/avantor-completes-acquisition-of-masterflex/ 2021-11-01T18:08:18+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/11/avantor-logo-303x237-1.png https://lifesciencesbc.ca/members/aurinia-pharmaceuticals-to-present-five-abstracts-at-asn-kidney-week-2021-and-acr-convergence-2021/ 2021-11-01T20:53:55+00:00 https://lifesciencesbc.ca/members/admare-bioinnovations-and-district-3-innovation-partner-to-provide-science-based-canadian-startups-more-cohesive-support-to-grow-into-industry-leaders/ 2021-11-02T17:56:22+00:00 https://lifesciencesbc.ca/members/lilly-to-supply-614000-additional-doses-of-abcellera-discovered-bamlanivimab-together-with-etesevimab-to-the-u-s-government-for-the-treatment-or-post-exposure-prevention-of-covid-19/ 2021-11-02T22:28:17+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-files-pct-patent-application-for-treating-neurodegenerative-disease-using-a-rare-cannabinoid/ 2021-11-03T15:32:49+00:00 https://lifesciencesbc.ca/members/clinicians-are-crucial-to-the-development-of-new-medical-technologies-and-therapeutic-candidates/ 2021-11-03T20:16:26+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/11/Baehl-303x237-1.png https://lifesciencesbc.ca/members/2022-scholar-and-research-trainee-competitions-applications-are-now-open/ 2021-11-03T21:36:42+00:00 https://lifesciencesbc.ca/members/eupraxia-pharmaceuticals-inc-announces-research-and-development-funding/ 2021-11-04T18:23:47+00:00 https://lifesciencesbc.ca/members/merck-and-ridgebacks-molnupiravir-an-oral-covid-19-antiviral-medicine-receives-first-authorization-in-the-world/ 2021-11-04T18:26:13+00:00 https://lifesciencesbc.ca/members/msfhr-funds-19-innovators-to-advance-made-in-bc-health-research-and-discoveries-for-improved-patient-care-the-2020-innovation-to-commercialization-and-health-professional-investigator-award-recip/ 2021-11-08T18:15:43+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/01/Michael-Smith.png https://lifesciencesbc.ca/members/innovative-medicines-canada-pmprb-guidelines-webinar-for-stakeholders/ 2021-11-08T18:17:44+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/01/Innovative-Medicine-Canada.png https://lifesciencesbc.ca/members/fda-approves-aurinia-pharmaceuticals-lupkynis-voclosporin-for-adult-patients-with-active-lupus-nephritis/ 2021-11-08T18:20:15+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/09/Aurinia-Logo-RBG-031620-v01-300x85.png https://lifesciencesbc.ca/members/kardium-announces-115m-in-new-financing-for-innovative-atrial-fibrillation-treatment/ 2021-11-08T18:22:30+00:00 https://lifesciencesbc.ca/members/ontario-bioscience-innovation-organization-announces-lifescience-bc-members-to-speak-at-2021-obio-investment-summit/ 2021-11-08T18:31:14+00:00 https://lifesciencesbc.ca/members/fasken-and-clinical-research-professionals-of-bc-recognized-for-quarter-century-of-clinical-research-support-and-service/ 2021-11-08T18:32:36+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/10/Clinical_Trials_BC_Logo_300-300x101.png https://lifesciencesbc.ca/members/innovative-medicines-canada-statement-regarding-eu-export-mechanism-for-covid-19-vaccines/ 2021-11-08T18:34:12+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/01/Innovative-Medicine-Canada.png https://lifesciencesbc.ca/members/precision-nanosystems-receives-contribution-from-the-government-of-canada-to-build-rna-medicine-biomanufacturing-centre/ 2021-11-08T18:36:33+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/11/PrecisionNanosystemsLogo-2-1-300x83.png https://lifesciencesbc.ca/members/inmed-announces-us4-5-million-private-placement/ 2021-11-08T18:41:32+00:00 https://lifesciencesbc.ca/members/neoleukin-therapeutics-to-participate-in-guggenheim-healthcare-talks-2021-oncology-days/ 2021-11-08T18:43:59+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/08/neoleukin-logo-stacked-fullcolor-square-rgb-300x300.jpg https://lifesciencesbc.ca/members/inmed-pharmaceuticals-to-report-second-quarter-fiscal-2021-financial-results/ 2021-11-08T18:46:19+00:00 https://lifesciencesbc.ca/members/replicel-ceo-provides-corporate-update/ 2021-11-08T18:49:12+00:00 https://lifesciencesbc.ca/members/immunoflex-receives-research-and-development-funding/ 2021-11-08T18:51:02+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/09/immunoflex-300x51.png https://lifesciencesbc.ca/members/msfhr-and-bc-ahsn-intend-to-join-forces-to-drive-discovery-and-innovation-in-bcs-health-research-enterprise/ 2021-11-08T18:53:44+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/01/Michael-Smith.png https://lifesciencesbc.ca/wp-content/uploads/2019/10/BCAHSN-300x70.jpg https://lifesciencesbc.ca/members/notch-therapeutics-closes-85-million-series-a-financing-to-develop-pipeline-of-renewable-stem-cell-derived-cancer-immunotherapies/ 2021-11-08T19:00:32+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/03/NOTCH_LOGO_RGB-300x85.png https://lifesciencesbc.ca/members/vanrxs-robotic-machines-for-drug-industry-catch-eye-of-u-s-med-giant/ 2021-11-08T21:35:58+00:00 https://lifesciencesbc.ca/members/dr-karen-gelmon-awarded-doctors-of-bc-terry-fox-medal/ 2021-11-08T23:05:06+00:00 https://lifesciencesbc.ca/members/zymeworks-to-present-at-upcoming-investor-conferences/ 2021-11-08T23:13:27+00:00 https://lifesciencesbc.ca/members/prompthealth-2-0-connects-you-with-the-wellness-pros-you-need/ 2021-11-10T16:33:13+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/11/@PromptHealth.png https://lifesciencesbc.ca/members/lifelabs-appoints-jennifer-cudlipp-as-chief-operating-officer/ 2021-11-12T17:11:06+00:00 https://lifesciencesbc.ca/members/making-more-health-together-2021-creating-sustainable-health-solutions-for-50-million-people-in-vulnerable-communities/ 2021-11-15T17:56:12+00:00 https://lifesciencesbc.ca/members/digital-technology-supercluster-brings-partners-together-to-develop-innovative-technology-to-support-wellbeing/ 2021-11-15T18:13:18+00:00 https://lifesciencesbc.ca/members/bc-cancer-summit-forging-the-path-forward/ 2021-11-15T18:25:52+00:00 https://lifesciencesbc.ca/members/chinook-therapeutics-announces-pricing-of-an-upsized-160-million-public-offering/ 2021-11-15T21:48:25+00:00 https://lifesciencesbc.ca/members/cytiva-young-scientist-network/ 2021-11-15T22:09:22+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/11/FEOs_WvWUAUfAUT-1.jpg https://lifesciencesbc.ca/members/admare-and-uottawa-work-together-to-translate-university-research-into-strong-new-canadian-life-science-companies/ 2021-11-16T19:46:17+00:00 https://lifesciencesbc.ca/members/evonik-now-offers-customizable-resomer-printpowder-for-3d-printing-of-personalized-implantable-medical-devices/ 2021-11-17T18:19:11+00:00 https://lifesciencesbc.ca/members/admare-bioinnovations-announces-successful-applicants-to-2021-2022-executive-institute/ 2021-11-18T17:26:10+00:00 https://lifesciencesbc.ca/members/variational-ai-secures-us3-5-million-in-seed-funding-to-apply-state-of-the-art-ai-platform-to-generate-novel-small-molecule-therapeutics-for-drug-development/ 2021-11-18T17:29:32+00:00 https://lifesciencesbc.ca/members/novo-nordisk-to-acquire-dicerna-pharmaceuticals-including-the-rnai-research-technology-platform/ 2021-11-19T19:03:22+00:00 https://lifesciencesbc.ca/members/a-new-initiative-for-diabetes-prevention-and-innovative-care-chum-launches-the-centre-dexpertise-en-diabete-an-initiative-supported-by-a-5m-donation-from-novo-nordisk/ 2021-11-19T19:26:06+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/11/Novo-Nordisk.jpg https://lifesciencesbc.ca/members/microbiome-insights-opens-office-in-ireland-to-better-serve-clients-in-europe/ 2021-11-22T17:09:57+00:00 https://lifesciencesbc.ca/members/roche-to-present-new-pivotal-data-at-ash-2021-from-broad-and-comprehensive-portfolio-challenging-treatment-standards-for-people-with-blood-disorders/ 2021-11-23T17:23:40+00:00 https://lifesciencesbc.ca/members/gsk-showcases-progress-from-the-dreamm-clinical-trial-programme-in-multiple-myeloma-at-the-2021-ash-annual-meeting/ 2021-11-23T17:41:08+00:00 https://lifesciencesbc.ca/members/silicon-valley-bank-and-growtogether-invite-you-to-join-us/ 2021-11-23T18:21:24+00:00 https://lifesciencesbc.ca/members/izotropics-breast-ct-radiation-imaging-subsystem-powered-on-and-takes-initial-images/ 2021-11-23T18:33:06+00:00 https://lifesciencesbc.ca/members/algernon-announces-positive-feedback-on-its-planned-phase-1-2a-dmt-human-stroke-study/ 2021-11-23T21:05:49+00:00 https://lifesciencesbc.ca/members/virtual-open-house-at-our-sites-in-vancouver-and-birmingham/ 2021-11-23T21:13:01+00:00 https://lifesciencesbc.ca/members/innovative-medicines-canada-introduces-new-chair-cole-pinnow/ 2021-11-23T21:34:40+00:00 https://lifesciencesbc.ca/members/hdr-recognized-by-architizer-as-one-of-10-pathbreaking-north-american-architecture-firms/ 2021-11-23T23:05:21+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-reports-second-quarter-fiscal-2021-financial-results/ 2021-11-23T23:53:18+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/02/Picture1-250x300.jpg https://lifesciencesbc.ca/wp-content/uploads/2021/02/Picture2-300x239.jpg https://lifesciencesbc.ca/wp-content/uploads/2021/02/Picture3-235x300.jpg https://lifesciencesbc.ca/members/kintara-therapeutics-announces-fiscal-second-quarter-2021-financial-results-and-provides-corporate-update/ 2021-11-23T23:54:56+00:00 https://lifesciencesbc.ca/members/praxis-announces-the-launch-of-the-praxis-sci-ideation-challenge/ 2021-11-23T23:55:48+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/02/PIC1-300x169.png https://lifesciencesbc.ca/members/aurinia-pharmaceuticals-to-release-fourth-quarter-and-year-end-2020-financial-results-on-february-24-2021/ 2021-11-23T23:56:41+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/09/Aurinia-Logo-RBG-031620-v01-300x85.png https://lifesciencesbc.ca/members/inmed-announces-closing-of-us4-5-million-private-placement/ 2021-11-23T23:57:57+00:00 https://lifesciencesbc.ca/members/how-a-canadian-firm-is-accelerating-the-development-of-therapeutics/ 2021-11-24T00:07:44+00:00 https://lifesciencesbc.ca/wp-content/uploads/2020/11/AbCellera_700x350_Accelevents-1-e1610658038365-300x157.png https://lifesciencesbc.ca/members/microbion-corporation-receives-additional-funding-support-from-the-cystic-fibrosis-foundation-to-speed-advancement-of-inhaled-pravibismane/ 2021-11-24T00:10:39+00:00 https://lifesciencesbc.ca/members/northview-lifesciences-invests-in-elevate-farms/ 2021-11-24T00:11:30+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/02/Northview-Logo-2color1-300x206.png https://lifesciencesbc.ca/members/aurinia-pharmaceuticals-to-present-at-the-svb-leerink-10th-annual-global-healthcare-conference/ 2021-11-24T00:14:39+00:00 https://lifesciencesbc.ca/members/chinook-therapeutics-and-evotec-announce-strategic-collaboration-to-discover-and-develop-novel-precision-medicines-for-chronic-kidney-diseases/ 2021-11-24T00:18:55+00:00 https://lifesciencesbc.ca/members/northview-lifesciences-congratulates-portfolio-perimeter-medical-imaging-on-achieving-u-s-fda-510k-clearance-for-oct-imaging-system/ 2021-11-24T00:19:59+00:00 https://lifesciencesbc.ca/members/aurinia-reports-fourth-quarter-and-full-year-2020-financial-results-and-recent-operational-highlights/ 2021-11-24T00:20:59+00:00 https://lifesciencesbc.ca/members/personalized-healthcare-with-prompt-health-the-new-wave-of-health-and-wellness/ 2021-11-24T00:22:19+00:00 https://lifesciencesbc.ca/members/aurinia-pharmaceuticals-to-present-at-three-upcoming-march-investor-conferences/ 2021-11-24T00:24:06+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Aurinia-1.jpg https://lifesciencesbc.ca/members/signalchem-enters-a-clinical-trial-collaboration-with-merck-to-evaluate-the-effect-of-slc-391-in-combination-with-keytruda-pembrolizumab-in-advanced-non-small-cell-lung-cancer/ 2021-11-24T00:32:12+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/signalchem-e1616645126860.png https://lifesciencesbc.ca/members/chinook-therapeutics-announces-first-patient-dosed-in-phase-2-affinity-basket-study-of-atrasentan-in-proteinuric-glomerular-diseases/ 2021-11-24T00:36:35+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/CHINOOK-THERAPEUTICS.jpg https://lifesciencesbc.ca/members/aurora-biomed-announces-health-canada-approval-for-fastep-rapid-covid-19-antigen-test/ 2021-11-24T00:41:19+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/Aurora-Biomed.png https://lifesciencesbc.ca/members/axolotl-biosciences-wins-the-judges-choice-prize-at-the-fastpitch-competition-held-at-2021-life-science-innovation-northwest-conference/ 2021-11-24T00:42:50+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Axolotl-1.jpg https://lifesciencesbc.ca/ecosystem/province-of-bc-announces-program-to-accelerate-manufacturing/ 2021-11-24T00:45:58+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/Province-of-BC.png https://lifesciencesbc.ca/members/26171/ 2021-11-24T00:47:30+00:00 https://lifesciencesbc.ca/members/astrazeneca-accelerates-early-oncology-pipeline-across-key-strategic-scientific-platforms-at-aacr/ 2021-11-24T00:49:59+00:00 https://lifesciencesbc.ca/members/bold-therapeutics-bold-100-effective-in-vitro-against-covid-19-variants/ 2021-11-24T00:53:07+00:00 https://lifesciencesbc.ca/members/biolytical-laboratories-recruiting-participants-in-support-of-their-new-1-minute-antibody-test-for-covid-19/ 2021-11-24T00:54:23+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/INSTI-COVID-19-Antibody-Study-Adertisement-CMP-scaled.jpg https://lifesciencesbc.ca/members/inmed-pharmaceuticals-achieves-2g-l-cannabinoid-yield-with-integrasyn/ 2021-11-24T00:59:27+00:00 https://lifesciencesbc.ca/members/ico-therapeutics-inc-announces-closing-of-upsized-subscription-receipt-private-placement/ 2021-11-24T01:05:54+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/ICO-THERAPEUTICS-300x200.png https://lifesciencesbc.ca/members/algernon-pharmaceuticals-announces-positive-feedback-from-u-s-fda-for-phase-1-ifenprodil-small-cell-lung-cancer-study/ 2021-11-24T17:32:50+00:00 https://lifesciencesbc.ca/members/health-research-foundation-announces-recipient-of-its-medal-of-honour/ 2021-11-24T20:17:00+00:00 https://lifesciencesbc.ca/members/imc-and-roche-canada-announce-scholarship-for-the-university-of-torontos-dalla-lana-school-of-public-health/ 2021-11-24T20:20:11+00:00 https://lifesciencesbc.ca/members/immunoprecise-to-present-at-the-benchmark-companys-discovery-one-on-one-virtual-video-investor-conference-on-thursday-december-2-2021/ 2021-11-24T22:44:55+00:00 https://lifesciencesbc.ca/members/visionary-biotech-player-carl-hansen-of-abcellera-named-canadas-ey-entrepreneur-of-the-year-2021/ 2021-11-24T22:59:56+00:00 https://lifesciencesbc.ca/members/generator-12-0-competition-call-for-applications/ 2021-11-29T21:12:24+00:00 https://lifesciencesbc.ca/members/gsk-appoints-phil-dormitzer-m-d-ph-d-as-global-head-of-vaccines-rd/ 2021-11-30T18:21:44+00:00 https://lifesciencesbc.ca/members/chinook-therapeutics-announces-formation-of-sanreno-therapeutics-a-joint-venture-to-develop-kidney-disease-therapies-in-china/ 2021-11-30T18:39:23+00:00 https://lifesciencesbc.ca/members/medtronic-receives-health-canada-license-for-gi-genius-intelligent-endoscopy-module-with-artificial-intelligence-system-for-colonoscopy/ 2021-11-30T21:34:07+00:00 https://lifesciencesbc.ca/members/inmed-welcomes-the-baymedica-team-meet-philip-barr-vp-of-discovery-research/ 2021-12-01T17:00:59+00:00 https://lifesciencesbc.ca/members/zymeworks-announces-second-janssen-bispecific-antibody-to-begin-clinical-development-utilizing-azymetric-and-efect-therapeutic-platforms/ 2021-12-01T17:57:38+00:00 https://lifesciencesbc.ca/members/clairvoyant-therapeutics-secures-over-3m-in-seed-funding/ 2021-12-02T20:14:09+00:00 https://lifesciencesbc.ca/members/abcellera-announces-the-appointment-of-neil-aubuchon-as-chief-commercial-officer/ 2021-12-02T20:22:05+00:00 https://lifesciencesbc.ca/members/silicon-valley-bank-named-amongst-americas-most-responsible-companies-2022/ 2021-12-02T20:34:51+00:00 https://lifesciencesbc.ca/members/eupraxia-pharmaceuticals-inc-provides-update-on-its-phase-2-trial-for-osteoarthritis-drug-candidate-ep-104iar/ 2021-12-03T00:17:32+00:00 https://lifesciencesbc.ca/ecosystem/inbc-appoints-jill-earthy-as-chief-executive-officer/ 2021-12-03T17:36:20+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/12/InBC-303x237-1.png https://lifesciencesbc.ca/wp-content/uploads/2021/12/Jill-Earthy-1.jpg https://lifesciencesbc.ca/ecosystem/trade-accelerator-program-indigenous-business-cohort/ 2021-12-03T19:24:49+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/11/tap-banner-ind.jpg https://lifesciencesbc.ca/members/abcellera-discovered-bamlanivimab-together-with-etesevimab-authorized-as-the-first-and-only-antibody-therapy-for-emergency-use-in-covid-19-patients-under-the-age-of-12/ 2021-12-03T23:34:49+00:00 https://lifesciencesbc.ca/members/merck-canada-announces-expansion-of-manufacturing-for-molnupiravir-an-investigational-oral-antiviral-medicine-for-the-treatment-of-covid-19/ 2021-12-06T17:17:58+00:00 https://lifesciencesbc.ca/members/stronger-immune-response-from-delaying-second-dose-of-covid-19-vaccine/ 2021-12-06T17:48:55+00:00 https://lifesciencesbc.ca/members/stronger-immune-response-from-delaying-second-dose-of-covid-19-vaccine-2/ 2021-12-06T17:54:01+00:00 https://lifesciencesbc.ca/members/chmp-recommends-eu-approval-of-actemra-roactemra-to-treat-patients-with-severe-covid-19/ 2021-12-06T18:06:00+00:00 https://lifesciencesbc.ca/members/roche-to-launch-sars-cov-2-flu-a-b-rapid-antigen-test-in-countries-accepting-the-ce-mark-to-enable-rapid-differentiation-of-viral-respiratory-infections/ 2021-12-06T18:11:21+00:00 https://lifesciencesbc.ca/members/ondine-biomedical-starts-trading-on-aim/ 2021-12-06T18:23:39+00:00 https://lifesciencesbc.ca/members/amgen-announces-new-data-being-presented-at-ash-2021/ 2021-12-06T22:29:58+00:00 https://lifesciencesbc.ca/members/pfizer-named-amongst-americas-most-responsible-companies-2022/ 2021-12-06T23:07:31+00:00 https://lifesciencesbc.ca/members/svb-financial-groups-expansion-into-tech-investment-banking-continues-with-new-senior-bankers-and-the-launch-of-technology-leveraged-finance-and-equity-capital-markets/ 2021-12-06T23:26:02+00:00 https://lifesciencesbc.ca/members/sonic-incytes-successfully-completes-series-a-raise-of-us7-3m-to-accelerate-velacurtm-commercialization/ 2021-12-07T17:02:05+00:00 https://lifesciencesbc.ca/members/nz-technologies-and-dupar-controls-announce-manufacturing-collaboration-poised-to-transform-elevator-interactions-with-touchless-technology/ 2021-12-07T17:24:13+00:00 https://lifesciencesbc.ca/members/abcellera-announces-changes-to-its-board-of-directors/ 2021-12-07T18:08:43+00:00 https://lifesciencesbc.ca/members/ema-accepts-regulatory-submission-for-olipudase-alfa-the-first-potential-therapy-for-asmd/ 2021-12-07T18:28:31+00:00 https://lifesciencesbc.ca/members/takeda-unveils-new-research-to-advance-patient-care-in-hematology-and-oncology-at-63rd-american-society-of-hematology-ash-annual-meeting/ 2021-12-07T18:34:28+00:00 https://lifesciencesbc.ca/members/lumira-co-leads-oncomyx-50-million-series-b-to-advance-a-novel-immuno-oncology-platform-that-delivers-multiple-cancer-killing-payloads/ 2021-12-08T16:51:55+00:00 https://lifesciencesbc.ca/members/novartis-presents-positive-phase-iii-results-for-cosentyx-in-children-with-active-enthesitis-related-arthritis-era-and-juvenile-psoriatic-arthritis-jpsa-at-acr-2021/ 2021-12-08T17:12:03+00:00 https://lifesciencesbc.ca/members/algernon-pharmaceuticals-completes-manufacturing-of-psychedelic-drug-dmt-appoints-uk-stroke-experts-for-phase-2/ 2021-12-08T17:20:26+00:00 https://lifesciencesbc.ca/members/recon-health-introduces-worlds-first-health-patch-with-core-body-temperature-measurement-powered-by-greenteg-calera-core-body-temperature-sensor/ 2021-12-08T23:21:00+00:00 https://lifesciencesbc.ca/members/pfizer-and-biontech-receive-u-s-fda-emergency-use-authorization-of-covid-19-vaccine-booster-for-individuals-16-years-and-older/ 2021-12-09T17:44:42+00:00 https://lifesciencesbc.ca/members/supporting-researchers-to-improve-patient-care-and-outcomes-2021-health-professional-investigator-awardees/ 2021-12-09T18:04:46+00:00 https://lifesciencesbc.ca/members/nominations-now-open-for-clinical-trials-bc-awards-2022/ 2021-12-09T18:44:16+00:00 https://lifesciencesbc.ca/members/medicago-and-gsk-announce-positive-phase-3-efficacy-and-safety-results-for-adjuvanted-plant-based-covid-19-vaccine-candidate/ 2021-12-09T18:55:24+00:00 https://lifesciencesbc.ca/members/bc-cancer-researchers-dr-peter-stirling-and-dr-david-huntsman-awarded-ovcan-ovarian-cancer-canada-cancer-research-society-grant/ 2021-12-10T00:55:06+00:00 https://lifesciencesbc.ca/members/ubc-launches-canadas-first-jdrf-centre-of-excellence-in-type-1-diabetes-research/ 2021-12-10T16:21:05+00:00 https://lifesciencesbc.ca/ecosystem/meet-the-2021-digital-health-canada-award-winners/ 2021-12-10T16:29:50+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/12/Dig-Health-Can-303x237-1.png https://lifesciencesbc.ca/members/applications-are-open-for-our-spring-2022-lab2launch-cohort/ 2021-12-10T22:28:18+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/12/L2L-lsbc-graphic.jpg https://lifesciencesbc.ca/members/norton-rose-fulbright-ranked-as-top-public-finance-team-in-refinitivs-us-municipals-review-for-underwriters-counsel/ 2021-12-13T19:06:22+00:00 https://lifesciencesbc.ca/members/nervgen-pharma-corp-closes-non-brokered-private-placement/ 2021-12-13T19:24:06+00:00 https://lifesciencesbc.ca/members/takeda-drives-continued-scientific-leadership-through-real-world-evidence-in-rare-hematological-diseases-at-ash-2021/ 2021-12-14T00:02:10+00:00 https://lifesciencesbc.ca/members/novo-nordisk-invests-more-than-dkk-17-bn-in-expansion-of-the-manufacturing-facilities-in-kalundborg-denmark/ 2021-12-14T00:19:40+00:00 https://lifesciencesbc.ca/members/immunoprecise-reports-financial-results-and-recent-business-highlights-for-second-quarter-fiscal-year-2022/ 2021-12-14T17:19:29+00:00 https://lifesciencesbc.ca/members/supporting-researchers-to-improve-patient-care-and-outcomes-2021-health-professional-investigator-awardees-2/ 2021-12-14T18:27:56+00:00 https://lifesciencesbc.ca/members/variational-ai-partners-with-the-university-of-british-columbia-and-admare-bioinnovations-to-develop-covid-19-therapeutic/ 2021-12-15T17:38:50+00:00 https://lifesciencesbc.ca/members/fasken-joins-open-cap-table-coalition/ 2021-12-15T18:24:28+00:00 https://lifesciencesbc.ca/members/rinvoq-upadacitinib-receives-u-s-fda-approval-for-active-psoriatic-arthritis/ 2021-12-15T18:30:44+00:00 https://lifesciencesbc.ca/members/starfish-medical-receives-canadas-most-admired-corporate-cultures-2021-award/ 2021-12-16T17:15:32+00:00 https://lifesciencesbc.ca/members/specific-biologics-closes-seed-financing-with-industry-leaders-lumira-ventures-and-admare-bioinnovations/ 2021-12-16T23:18:44+00:00 https://lifesciencesbc.ca/members/merck-and-ridgeback-announce-publication-of-phase-3-study-of-molnupiravir-an-investigational-oral-antiviral-covid-19-treatment-in-the-new-england-journal-of-medicine/ 2021-12-16T23:33:17+00:00 https://lifesciencesbc.ca/members/xevudy-sotrovimab-granted-marketing-authorisation-by-the-european-commission-for-the-early-treatment-of-covid-19/ 2021-12-17T16:58:17+00:00 https://lifesciencesbc.ca/members/mynd-life-sciences-acquires-rights-for-the-use-of-psychedelics-to-treat-alzheimers-disease-and-other-dementias/ 2021-12-17T17:09:59+00:00 https://lifesciencesbc.ca/members/how-ey-entrepreneur-of-the-year-2021-winner-abcellera-is-building-a-biotech-powerhouse/ 2021-12-17T17:28:45+00:00 https://lifesciencesbc.ca/members/zymeworks-names-biotechnology-industry-leader-kenneth-galbraith-as-chair-and-ceo-to-succeed-dr-ali-tehrani-co-founder/ 2022-01-10T22:01:05+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/Zymeworks-Inc..jpg https://lifesciencesbc.ca/members/pfizer-and-biontech-sign-new-global-collaboration-agreement-to-develop-first-mrna-based-shingles-vaccine/ 2022-01-10T22:05:58+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Pfizer%20Canada%20Inc..jpg https://lifesciencesbc.ca/members/acuitas-therapeutics-co-founder-dr-pieter-cullis-named-officer-of-the-order-of-canada/ 2022-01-10T22:08:26+00:00 https://lifesciencesbc.ca/members/abcelleras-statement-on-the-neutralization-activity-of-its-monoclonal-antibody-therapies-against-the-omicron-variant-of-concern/ 2022-01-11T20:13:15+00:00 https://lifesciencesbc.ca/members/pfizer-enters-into-agreement-with-acuitas-therapeutics-for-lipid-nanoparticle-delivery-system-for-use-in-mrna-vaccines-and-therapeutics/ 2022-01-11T22:28:41+00:00 https://lifesciencesbc.ca/members/takeda-to-acquire-adaptate-biotherapeutics-to-develop-novel-gamma-delta-%ce%b3%ce%b4-t-cell-engager-therapies-targeting-solid-tumors/ 2022-01-11T22:45:54+00:00 https://lifesciencesbc.ca/members/novartis-in-licenses-covid-19-treatment-ensovibep-from-molecular-partners/ 2022-01-11T22:56:45+00:00 https://lifesciencesbc.ca/members/novartis-announces-collaboration-with-alnylam-to-explore-targeted-therapy-to-restore-liver-function/ 2022-01-11T22:57:30+00:00 https://lifesciencesbc.ca/members/roche-introduces-cobas-infinity-edge-a-new-open-digital-ecosystem-for-point-of-care-professionals-driving-improved-patient-outcomes-and-operational-efficiencies-in-healthcare/ 2022-01-11T23:24:37+00:00 https://lifesciencesbc.ca/members/amgen-and-arrakis-therapeutics-announce-multi-target-collaboration-to-identify-novel-rna-degrader-small-molecule-therapeuticsevent-details/ 2022-01-11T23:36:19+00:00 https://lifesciencesbc.ca/members/abl-bio-enters-global-collaboration-and-license-agreement-with-sanofi-to-advance-abl301-for-the-treatment-of-parkinsons-disease/ 2022-01-12T17:53:01+00:00 https://lifesciencesbc.ca/members/eyam-vaccines-and-immunotherapeutics-welcomes-new-board-members-and-scientific-advisors/ 2022-01-12T17:59:14+00:00 https://lifesciencesbc.ca/members/bold-therapeutics-extends-south-korea-option-agreement-for-bold-100-a-first-in-class-anti-resistance-therapeutic/ 2022-01-13T19:30:46+00:00 https://lifesciencesbc.ca/members/nano-solutions-for-macro-problems-5-things-to-know-about-lithuanias-life-sciences-industry/ 2022-01-13T21:46:33+00:00 https://lifesciencesbc.ca/wp-content/uploads/2022/01/Marius-Jovaisa_biotechnologies2.jpg https://lifesciencesbc.ca/members/spinal-cord-injury-research-receives-24-million-funding-support/ 2022-01-14T17:28:50+00:00 https://lifesciencesbc.ca/members/pfizer-receives-health-canada-authorization-for-covid-19-oral-treatment/ 2022-01-18T17:04:11+00:00 https://lifesciencesbc.ca/members/pfizer-to-boost-covid-19-pill-production-with-french-deal/ 2022-01-18T17:55:12+00:00 https://lifesciencesbc.ca/members/merck-and-ridgeback-announce-supply-agreement-with-unicef-for-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine/ 2022-01-18T19:18:10+00:00 https://lifesciencesbc.ca/ecosystem/applications-are-open-for-entrepreneurshipubcs-spring-2022-lab2launch-program/ 2022-01-18T19:29:04+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/entrepreneurship@UBC.jpg https://lifesciencesbc.ca/members/prominent-neuroscientist-to-advance-brain-research-through-new-sfu-institute/ 2022-01-18T19:31:27+00:00 https://lifesciencesbc.ca/members/essa-pharma-announces-first-patient-dosed-in-a-phase-1-2-clinical-trial-of-epi-7386-in-combination-with-enzalutamide-in-patients-with-metastatic-castration-resistant-prostate-cancer/ 2022-01-19T18:54:45+00:00 https://lifesciencesbc.ca/members/amplitude-ventures-altaml-pen-partnership-to-build-ai-biotech-companies/ 2022-01-19T19:04:30+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Amplitude-1.jpg https://lifesciencesbc.ca/members/inmed-launches-cannabicitran-cbt-expanding-its-rare-cannabinoid-portfolio-for-the-health-and-wellness-sector/ 2022-01-19T19:12:01+00:00 https://lifesciencesbc.ca/members/tony-wood-appointed-chief-scientific-officer-designate-gsk/ 2022-01-19T19:23:24+00:00 https://lifesciencesbc.ca/members/acuitas-announces-sponsorship-for-the-vancouver-athletic-football-club/ 2022-01-19T19:27:41+00:00 https://lifesciencesbc.ca/members/sandoz-and-aequus-agree-to-1-year-extension-on-vistitan-in-canada/ 2022-01-19T21:28:57+00:00 https://lifesciencesbc.ca/members/cytiva-and-nucleus-biologics-join-forces-to-accelerate-development-of-custom-cell-media-for-cell-and-gene-therapies/ 2022-01-20T23:33:16+00:00 https://lifesciencesbc.ca/members/takeda-canada-launches-digital-health-innovation-challenge-to-canadas-inspiring-tech-community/ 2022-01-21T17:54:31+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/LSBC-industry-news-e1637957595910.png https://lifesciencesbc.ca/members/new-national-wage-subsidy-will-integrate-skilled-newcomers-into-canadas-bio-economy/ 2022-01-24T17:14:30+00:00 https://lifesciencesbc.ca/members/merck-provides-u-s-and-japan-regulatory-update-for-gefapixant/ 2022-01-24T19:49:02+00:00 https://lifesciencesbc.ca/members/acuitas-therapeutics-names-miranda-lam-as-chief-legal-officer-sr-director-business-development/ 2022-01-25T17:41:15+00:00 https://lifesciencesbc.ca/members/xenon-pharmaceuticals-announces-collaboration-with-neurocrine-biosciences-achieves-15-0-million-regulatory-milestone/ 2022-01-25T17:45:25+00:00 https://lifesciencesbc.ca/members/algernon-pharmaceuticals-discloses-novel-salt-patent-strategy-as-part-of-its-psychedelic-drug-dmt-intellectual-property/ 2022-01-25T22:02:19+00:00 https://lifesciencesbc.ca/members/acuitas-announces-key-partnership-with-science-world/ 2022-01-25T22:18:13+00:00 https://lifesciencesbc.ca/members/aequus-extends-commercial-agreement-for-specialty-product-tacrolimus-ir-in-canada/ 2022-01-25T22:21:10+00:00 https://lifesciencesbc.ca/members/sierra-oncology-announces-momelotinib-achieved-statistically-significant-benefit-on-symptoms-anemia-and-splenic-size-in-the-pivotal-momentum-study-for-myelofibrosis/ 2022-01-25T22:27:06+00:00 https://lifesciencesbc.ca/members/gowling-wlg-partner-michael-watson-awarded-court-of-appeal-medallion/ 2022-01-25T22:35:18+00:00 https://lifesciencesbc.ca/members/roches-evrysdi-risdiplam-granted-fda-priority-review-for-treatment-of-pre-symptomatic-babies-under-2-months-of-age-with-spinal-muscular-atrophy-sma/ 2022-01-25T22:40:41+00:00 https://lifesciencesbc.ca/members/quark-venture-inc-and-gf-securities-participate-in-keros-therapeutics-23-million-series-b-financing/ 2022-01-25T22:41:27+00:00 https://lifesciencesbc.ca/members/u-s-fda-approves-second-indication-for-skyrizi-risankizumab-rzaa-to-treat-adults-with-active-psoriatic-arthritis/ 2022-01-25T22:44:45+00:00 https://lifesciencesbc.ca/ecosystem/michael-smith-health-research-bc-2022-suite-of-funding-opportunities/ 2022-01-27T17:36:26+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/11/Michael-Smith-HRBC-303x237-2.png https://lifesciencesbc.ca/members/takeda-canada-launches-digital-health-innovation-challenge-to-canadas-inspiring-tech-community-2/ 2022-01-28T19:37:29+00:00 https://lifesciencesbc.ca/members/numinus-identified-as-a-licensed-psilocybin-supplier-by-health-canada/ 2022-01-31T20:51:30+00:00 https://lifesciencesbc.ca/wp-content/uploads/2022/01/numinus.jpg https://lifesciencesbc.ca/members/gandeeva-raises-40m-in-series-a-funding-to-develop-novel-therapies-based-on-precision-imaging-of-protein-drug-interactions/ 2022-01-31T21:55:53+00:00 https://lifesciencesbc.ca/members/algernon-pharmaceuticals-announces-notice-of-allowance-for-ifenprodil-patent-application-for-idiopathic-pulmonary-fibrosis/ 2022-02-01T17:07:11+00:00 https://lifesciencesbc.ca/members/dan-misutka-joins-gowling-wlgs-administrative-law-group/ 2022-02-01T17:24:01+00:00 https://lifesciencesbc.ca/members/merck-and-ridgebacks-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-demonstrated-activity-against-omicron-variant-in-in-vitro-studies/ 2022-02-01T17:29:35+00:00 https://lifesciencesbc.ca/ecosystem/medtech-talent-accelerator-students-available-for-jan-may-sept-2022/ 2022-02-02T22:09:45+00:00 https://lifesciencesbc.ca/wp-content/uploads/2022/01/Untitled-design-34.png https://lifesciencesbc.ca/members/acuitas-announces-sponsorship-for-the-2022-greater-vancouver-regional-science-fair/ 2022-02-02T22:10:56+00:00 https://lifesciencesbc.ca/members/vancouver-based-zymeworks-announces-closing-of-115-million-new-financing-via-public-offering/ 2022-02-02T23:22:21+00:00 https://lifesciencesbc.ca/members/fda-approves-roches-vabysmo-the-first-bispecific-antibody-for-the-eye-to-treat-two-leading-causes-of-vision-loss/ 2022-02-03T00:46:36+00:00 https://lifesciencesbc.ca/members/european-commission-approves-lorviqua-lorlatinib-as-a-first-line-treatment-for-alk-positive-advanced-lung-cancer/ 2022-02-03T00:52:48+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/pfizer2019.jpeg https://lifesciencesbc.ca/members/chmp-recommends-approval-of-dupixent-dupilumab-for-children-aged-6-to-11-years-with-severe-asthma-with-type-2-inflammation/ 2022-02-03T04:14:28+00:00 https://lifesciencesbc.ca/members/chmp-issues-positive-opinion-to-expand-jardiance-empagliflozin-indication-based-on-unprecedented-benefit-in-adult-heart-failure-patients-with-preserved-ejection-fraction/ 2022-02-03T04:16:29+00:00 https://lifesciencesbc.ca/members/sonic-incytes-medical-corp-appoints-new-ceo-and-chair-to-accelerate-growth/ 2022-02-03T17:56:22+00:00 https://lifesciencesbc.ca/members/medtronic-continuous-glucose-monitoring-to-be-reimbursed-for-eligible-alberta-youth-living-with-diabetes/ 2022-02-04T17:28:48+00:00 https://lifesciencesbc.ca/members/cytiva-fuels-biotech-development-in-australia-and-new-zealand/ 2022-02-04T17:32:46+00:00 https://lifesciencesbc.ca/members/ionsgate-preclinical-services-and-insilicotrials-form-partnership/ 2022-02-07T17:46:52+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/IONSGATE-1.jpg https://lifesciencesbc.ca/members/zymeworks-announces-participation-in-upcoming-investor-conferences/ 2022-02-08T18:20:30+00:00 https://lifesciencesbc.ca/members/merck-and-ridgeback-announce-that-3-1-million-courses-of-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-have-been-supplied-to-the-u-s-government-for-use-in-the-united-states/ 2022-02-08T18:29:19+00:00 https://lifesciencesbc.ca/members/zucara-therapeutics-announces-publication-of-preclinical-study-demonstrating-zt-01s-ability-to-restore-glucagon-release-in-type-1-diabetes/ 2022-02-08T19:24:51+00:00 https://lifesciencesbc.ca/members/ondine-biomedical-treats-first-patients-in-nasal-photodisinfection-us-phase-2-for-the-prevention-of-post-operative-infections/ 2022-02-08T19:39:09+00:00 https://lifesciencesbc.ca/members/fda-approves-enjaymo-sutimlimab-jome-first-treatment-for-use-in-patients-with-cold-agglutinin-disease/ 2022-02-08T20:21:46+00:00 https://lifesciencesbc.ca/members/algernon-pharmaceuticals-announces-completion-of-enrollment-in-its-phase-2-study-of-ifenprodil-for-ipf-and-chronic-cough/ 2022-02-08T20:27:46+00:00 https://lifesciencesbc.ca/members/zymeworks-to-host-fourth-quarter-and-full-year-2021-results-conference-call/ 2022-02-09T22:42:24+00:00 https://lifesciencesbc.ca/members/olipudase-alfa-shown-to-provide-sustained-improvement-across-multiple-clinical-manifestations-of-asmd/ 2022-02-09T22:52:42+00:00 https://lifesciencesbc.ca/members/company-led-by-ubc-professor-raises-us40m-to-advance-drug-discovery/ 2022-02-10T00:06:25+00:00 https://lifesciencesbc.ca/wp-content/uploads/2022/02/Untitled-design-47.png https://lifesciencesbc.ca/ecosystem/biotecanada-announces-the-launch-of-bioech-connec/ 2022-02-10T01:29:05+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/LSBC-industry-news-e1637957595910.png https://lifesciencesbc.ca/members/cannabinoids-see-explosive-growth-opportunity/ 2022-02-10T17:30:27+00:00 https://lifesciencesbc.ca/members/delta-vs-kappa-study-examines-molecular-factors-that-fuel-covid-19-variants/ 2022-02-10T17:39:26+00:00 https://lifesciencesbc.ca/members/biotalent-canada-launch-the-2022-catalyst-award-for-top-new-hire/ 2022-02-10T17:51:53+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/LSBC-industry-news-e1637957595910.png https://lifesciencesbc.ca/members/phase-3-clinical-trial-confirms-sanotizes-breakthrough-treatment-is-99-effective-against-covid-19-receives-regulatory-approval-in-india/ 2022-02-11T18:41:47+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-strengthens-its-commercial-leadership-team-with-the-appointment-of-vice-president-of-sales-and-marketing-for-baymedica/ 2022-02-15T17:16:54+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-reports-second-quarter-fiscal-2022-financial-results-and-provides-business-update/ 2022-02-15T17:22:26+00:00 https://lifesciencesbc.ca/members/avantor-breaks-ground-on-new-distribution-center-to-serve-growing-biopharmaceutical-industry-in-ireland/ 2022-02-15T17:53:58+00:00 https://lifesciencesbc.ca/members/lynparza-olaparib-plus-abiraterone-reduced-risk-of-disease-progression-or-death-by-34-versus-abiraterone-in-first-line-metastatic-castration-resistant-prostate-cancer-regardless-of-biomarker/ 2022-02-15T18:07:58+00:00 https://lifesciencesbc.ca/members/who-grants-prequalification-of-actemra-roactemra-for-patients-with-severe-or-critical-covid-19/ 2022-02-15T21:55:35+00:00 https://lifesciencesbc.ca/members/abcellera-discovered-antibody-bebtelovimab-receives-u-s-fda-emergency-use-authorization-for-the-treatment-of-mild-to-moderate-covid-19/ 2022-02-15T22:01:03+00:00 https://lifesciencesbc.ca/members/lilly-to-supply-up-to-600000-doses-of-abcellera-discovered-antibody-bebtelovimab-to-the-u-s-government-in-ongoing-effort-to-provide-covid-19-treatments/ 2022-02-15T22:07:58+00:00 https://lifesciencesbc.ca/members/deloitte-invests-750m-in-healthcare-consumer-and-financial-services-businesses/ 2022-02-16T20:07:53+00:00 https://lifesciencesbc.ca/members/abbvie-and-the-university-of-toronto-establish-endowed-chair-in-ethnodermatology/ 2022-02-16T20:11:29+00:00 https://lifesciencesbc.ca/members/merck-announces-new-leadership-for-human-health-business/ 2022-02-16T20:19:26+00:00 https://lifesciencesbc.ca/members/pfizer-and-opkos-once-weekly-ngenla-somatrogon-injection-receives-marketing-authorization-in-european-union-for-treatment-of-pediatric-growth-hormone-deficiency/ 2022-02-16T20:23:39+00:00 https://lifesciencesbc.ca/members/deloitte-canada-commits-175000-annually-for-three-years-to-indspire-to-invest-in-indigenous-education/ 2022-02-16T20:27:19+00:00 https://lifesciencesbc.ca/members/new-analysis-demonstrates-uplizna-inebilizumab-cdon-reduces-severity-of-attacks-associated-with-neuromyelitis-optica-spectrum-disorder-nmosd/ 2022-02-16T21:12:14+00:00 https://lifesciencesbc.ca/members/emd-serono-launches-new-sustainable-slim-pack-for-fertility-medication/ 2022-02-18T17:58:28+00:00 https://lifesciencesbc.ca/members/apply-to-entrepreneurshipubcs-core-venture-building-program/ 2022-02-23T00:50:50+00:00 https://lifesciencesbc.ca/members/horizon-therapeutics-plc-initiates-phase-3-clinical-trial-optic-j-in-japan-evaluating-teprotumumab-for-the-treatment-of-active-thyroid-eye-disease-ted/ 2022-02-23T20:58:02+00:00 https://lifesciencesbc.ca/members/gsk-provides-update-on-phase-iii-rsv-maternal-vaccine-candidate-programme/ 2022-02-23T21:07:13+00:00 https://lifesciencesbc.ca/members/gsk-announces-independent-consumer-healthcare-company-is-to-be-called-haleon/ 2022-02-23T21:15:08+00:00 https://lifesciencesbc.ca/members/sanofi-and-gsk-to-seek-regulatory-authorization-for-covid-19-vaccine/ 2022-02-23T21:21:07+00:00 https://lifesciencesbc.ca/members/acquisition-of-exelead-completed-plans-to-invest-more-than-e-500-million-in-technology-scale-up/ 2022-02-23T21:31:40+00:00 https://lifesciencesbc.ca/members/astrazeneca-to-supply-canada-with-100000-doses-of-evusheld-a-long-acting-antibody-combination-for-the-prevention-of-covid-19/ 2022-02-23T21:37:04+00:00 https://lifesciencesbc.ca/members/algernon-pharmaceuticals-begins-manufacturing-of-repirinast-and-launches-new-chronic-kidney-disease-research-program/ 2022-02-23T21:44:55+00:00 https://lifesciencesbc.ca/members/evonik-strengthens-world-scale-methionine-production-hub-in-the-u-s/ 2022-02-23T21:49:26+00:00 https://lifesciencesbc.ca/members/budget-2022-supports-genome-bc-to-advance-life-sciences/ 2022-02-23T21:51:48+00:00 https://lifesciencesbc.ca/members/quinly-automates-prusa-in-11-countries/ 2022-02-23T22:21:53+00:00 https://lifesciencesbc.ca/members/delta-vs-kappa-study-examines-molecular-factors-that-fuel-covid-19-variants-2/ 2022-02-24T17:16:05+00:00 https://lifesciencesbc.ca/members/fda-grants-bi-1015550-breakthrough-therapy-designation-for-idiopathic-pulmonary-fibrosis/ 2022-02-24T20:36:21+00:00 https://lifesciencesbc.ca/members/second-phase-3-induction-study-confirms-upadacitinib-rinvoq-improved-clinical-and-endoscopic-outcomes-in-patients-with-crohns-disease/ 2022-02-24T21:03:52+00:00 https://lifesciencesbc.ca/members/medicago-and-gsk-announce-the-approval-by-health-canada-of-covifenz-an-adjuvanted-plant-based-covid-19-vaccine/ 2022-02-24T21:09:01+00:00 https://lifesciencesbc.ca/ecosystem/cdc-advisory-committee-on-immunization-practices-votes-to-recommend-ticovac-pfizers-tick-borne-encephalitis-tbe-vaccine-for-those-at-risk-of-virus-exposure/ 2022-02-24T21:16:15+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Pfizer%20Canada%20Inc..jpg https://lifesciencesbc.ca/members/31589/ 2022-02-25T17:40:08+00:00 https://lifesciencesbc.ca/members/us-fda-approves-jardiance-empagliflozin-to-treat-adults-with-heart-failure-regardless-of-left-ventricular-ejection-fraction/ 2022-02-25T17:50:53+00:00 https://lifesciencesbc.ca/members/bold-therapeutics-successfully-completes-phase-1b-trial-and-advances-into-global-phase-2-trial-of-bold-100-in-the-treatment-of-advanced-gi-cancers/ 2022-03-01T18:19:33+00:00 https://lifesciencesbc.ca/members/interim-phase-4-data-support-takhzyro-lanadelumab-as-an-effective-treatment-to-reduce-attacks-in-hereditary-angioedema-patients/ 2022-03-01T21:20:55+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Takeda.jpg https://lifesciencesbc.ca/members/the-genesis-of-shingles-awareness-week/ 2022-03-01T21:30:27+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/GSK-1.jpg https://lifesciencesbc.ca/members/late-breaking-data-at-2022-aaaai-annual-meeting-show-dupixent-dupilumab-significantly-improved-signs-and-symptoms-of-eosinophilic-esophagitis/ 2022-03-01T23:40:19+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Sanofi.jpg https://lifesciencesbc.ca/members/late-breaking-phase-3-data-at-2022-aaaai-annual-meeting-show-dupixent-dupilumab-significantly-reduced-itch-and-hives-in-patients-with-chronic-spontaneous-urticaria/ 2022-03-01T23:47:35+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Sanofi.jpg https://lifesciencesbc.ca/members/the-globe-and-mail-quotes-john-pecman-in-an-article-on-global-antitrust-reforms/ 2022-03-01T23:50:35+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/FASKEN-1.jpg https://lifesciencesbc.ca/members/evonik-launches-first-renewable-isophorone-based-products/ 2022-03-01T23:57:40+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/Evonik-for-website.png https://lifesciencesbc.ca/members/aon-acquires-tyche-platform-to-expand-insurance-consulting-capabilities-for-clients/ 2022-03-02T00:02:21+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/AON-1.png https://lifesciencesbc.ca/members/boehringer-ingelheim-and-lifebit-announce-partnership-to-capture-transformational-value-of-health-data/ 2022-03-02T00:05:53+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/boehringer-square.jpg https://lifesciencesbc.ca/members/nervgen-pharma-reports-2021-year-end-results-and-provides-update-on-phase-1-study/ 2022-03-02T00:10:39+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/NervGen%20Pharma.jpg https://lifesciencesbc.ca/members/gsk-introduces-haleon-to-investors/ 2022-03-02T20:01:38+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/GSK-1.jpg https://lifesciencesbc.ca/members/zymeworks-co-founder-former-ceo-ali-tehrani-joins-amplitude-ventures-as-venture-partner/ 2022-03-02T20:22:58+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Amplitude-1.jpg https://lifesciencesbc.ca/members/canadians-are-encouraged-to-rethink-rare-on-rare-disease-day/ 2022-03-02T20:38:17+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Takeda.jpg https://lifesciencesbc.ca/members/roche-announces-donation-of-essential-medicines-to-ukraine/ 2022-03-02T20:51:02+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/12/Roche-303x237-2.png https://lifesciencesbc.ca/members/fasken-partners-with-black-boys-code-as-official-legal-services-provider/ 2022-03-02T20:55:28+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/FASKEN-1.jpg https://lifesciencesbc.ca/members/st-pauls-patient-worlds-first-to-undergo-new-type-of-heart-valve-surgery/ 2022-03-02T21:11:43+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/st-paul.jpg https://lifesciencesbc.ca/ecosystem/fda-publishes-proposed-rule-to-align-quality-system-requirements-with-international-standards/ 2022-03-02T23:09:12+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/LSBC-industry-news-e1637957595910.png https://lifesciencesbc.ca/ecosystem/new-life-sciences-investment-helps-build-stronger-b-c/ 2022-03-03T18:30:59+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/LSBC-industry-news-e1637957595910.png https://lifesciencesbc.ca/members/sanofi-to-spend-1-billion-on-developing-mrna-vaccines-in-france/ 2022-03-07T22:25:51+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Sanofi.jpg https://lifesciencesbc.ca/ecosystem/abbvie-completes-acquisition-of-syndesi-therapeutics-for-up-to-usd1-billion/ 2022-03-07T22:28:47+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/LSBC-industry-news-e1637957595910.png https://lifesciencesbc.ca/members/inmed-to-present-at-the-34th-annual-roth-conference/ 2022-03-08T17:42:12+00:00 https://lifesciencesbc.ca/members/medtronic-continuous-glucose-monitoring-to-be-reimbursed-for-eligible-people-living-with-type-1-diabetes-in-ontario/ 2022-03-08T19:53:04+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Medtronic%20Of%20Canada%20Ltd.jpg https://lifesciencesbc.ca/members/improving-albertas-patient-care-alberta-precision-laboratories-and-roche-diagnostics-join-forces-to-ensure-accurate-diagnosis-and-time-saving-through-provincial-integration-and-standardizati/ 2022-03-08T19:58:22+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/12/Roche-303x237-2.png https://lifesciencesbc.ca/members/global-biotechnology-leader-amgen-breaks-ground-on-new-manufacturing-facility-in-north-carolina/ 2022-03-08T20:02:30+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/AMGEN%20BC.jpg https://lifesciencesbc.ca/members/jardiance-empagliflozin-becomes-the-first-and-only-approved-treatment-in-europe-for-adults-with-symptomatic-chronic-heart-failure-regardless-of-ejection-fraction/ 2022-03-08T20:18:45+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/boehringer-ingelheim-ticker.jpg https://lifesciencesbc.ca/ecosystem/period-reduced-for-keeping-clinical-trial-records-for-drugs-and-natural-health-products/ 2022-03-08T20:27:27+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/LSBC-industry-news-e1637957595910.png https://lifesciencesbc.ca/members/climb-to-fight-cancer/ 2022-03-08T20:31:08+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Takeda.jpg https://lifesciencesbc.ca/members/izotropic-establishing-engineering-and-development-facility-in-the-usa/ 2022-03-08T20:44:00+00:00 https://lifesciencesbc.ca/wp-content/uploads/2022/03/izotropic-corporation-2.png https://lifesciencesbc.ca/members/horizon-therapeutics-plc-announces-fda-has-granted-priority-review-of-the-supplemental-biologics-license-application-sbla-for-the-concomitant-use-of-krystexxa-pegloticase-injection-plus-meth/ 2022-03-08T20:50:28+00:00 https://lifesciencesbc.ca/ecosystem/moderna-global-strategy-sets-sights-on-15-priority-pathogens/ 2022-03-08T20:54:17+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/LSBC-industry-news-e1637957595910.png https://lifesciencesbc.ca/lsbc-news/life-sciences-bc-announces-presenting-companies-pitching-at-invest-in-the-west-presented-by-amplitude-ventures/ 2022-03-09T18:17:01+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/LSBC-in-the-news-e1634859777372.png https://lifesciencesbc.ca/ecosystem/moderna-extends-patent-waiver-for-covid-vaccine-but-only-for-lower-income-countries/ 2022-03-10T21:55:27+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/LSBC-industry-news-e1637957595910.png https://lifesciencesbc.ca/ecosystem/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd/ 2022-03-17T17:04:36+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/LSBC-industry-news-e1637957595910.png https://lifesciencesbc.ca/ecosystem/castl-moves-to-establish-biopharma-manufacturing-training-facility-in-charlottetown/ 2022-03-17T17:22:03+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/LSBC-industry-news-e1637957595910.png https://lifesciencesbc.ca/members/an-open-letter-on-ukraine-from-daniel-oday-chairman-ceo-of-gilead/ 2022-03-17T23:25:36+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/GILEAD-1.jpg https://lifesciencesbc.ca/members/inmed-announces-management-changes/ 2022-03-21T17:38:46+00:00 https://lifesciencesbc.ca/members/evonik-and-asiga-collaborate-on-photopolymer-based-3d-printing-for-large-scale-industrial-manufacturing/ 2022-03-22T17:23:34+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/Evonik-for-website.png https://lifesciencesbc.ca/ecosystem/moderna-says-vaccine-results-for-kids-under-6-are-encouraging-will-file-for-authorization-soon/ 2022-03-24T16:23:40+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/LSBC-industry-news-e1637957595910.png https://lifesciencesbc.ca/ecosystem/studies-suggest-links-between-covid-19-and-diabetes-pregnancy-risks-and-dementia/ 2022-03-24T16:24:30+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/LSBC-industry-news-e1637957595910.png https://lifesciencesbc.ca/members/lifemine-therapeutics-and-gsk-enter-drug-discovery-and-development-alliance/ 2022-03-24T18:28:45+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/GSK-1.jpg https://lifesciencesbc.ca/members/research-shows-lower-dose-drug-strategy-for-severe-covid-19-patients-both-clinically-and-economically-effective/ 2022-03-24T18:29:13+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/VCHRI_logo_RGB_transparent-1.png https://lifesciencesbc.ca/members/roche-donates-additional-medicines-and-diagnostics-for-ukraine/ 2022-03-24T18:30:18+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/12/Roche-303x237-2.png https://lifesciencesbc.ca/members/nervgen-pharma-to-present-at-2022-virtual-growth-conference-presented-by-maxim-group-engages-apaton-finance-to-provide-investor-relations-services-in-europe/ 2022-03-24T18:31:21+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/NervGen%20Pharma.jpg https://lifesciencesbc.ca/members/applications-now-open-for-our-2022-health-professional-investigator-competition/ 2022-03-24T18:49:31+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/11/Michael-Smith-HRBC-303x237-2.png https://lifesciencesbc.ca/members/fda-approves-mercks-keytruda-pembrolizumab-for-patients-with-msi%e2%80%91h-dmmr-advanced-endometrial-carcinoma-who-have-disease-progression-following-prior-systemic-therapy-in-any-se/ 2022-03-25T20:38:47+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Merck%20Canada%20Inc.jpg https://lifesciencesbc.ca/members/a-fit-out-fit-for-daiya-foods/ 2022-03-25T20:39:11+00:00 https://lifesciencesbc.ca/wp-content/uploads/2022/01/wales.jpg https://lifesciencesbc.ca/members/horizon-therapeutics-and-iapb-partner-to-advocate-for-better-eye-health/ 2022-03-25T20:40:06+00:00 https://lifesciencesbc.ca/members/evonik-invests-in-new-rohacell-production-facility/ 2022-03-25T20:40:30+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/Evonik-for-website.png https://lifesciencesbc.ca/members/nanovation-therapeutics-launches-uk-hub/ 2022-03-25T20:41:41+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/NanoVation.png https://lifesciencesbc.ca/members/dr-brad-nelson-recipient-of-the-canadian-society-for-immunologys-2022-hardy-cinader-award/ 2022-03-25T20:42:11+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/BC%20Cancer.jpg https://lifesciencesbc.ca/members/mercks-keytruda-pembrolizumab-significantly-improved-disease-free-survival-dfs-versus-placebo-as-adjuvant-therapy-in-patients-with-stage-ib-iiia-non-small-cell-lung-cancer-nsclc-r/ 2022-03-25T20:42:42+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Merck%20Canada%20Inc.jpg https://lifesciencesbc.ca/ecosystem/the-government-of-canada-announces-additional-funding-to-four-safer-supply-pilot-projects/ 2022-03-25T20:43:14+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/LSBC-industry-news-e1637957595910.png https://lifesciencesbc.ca/members/high-tech-mouthguard-tracks-head-impacts-during-varsity-hockey-playoffs/ 2022-03-25T20:43:52+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/University-of-British-Columbia.jpg https://lifesciencesbc.ca/members/evonik-enters-new-era-of-cleaning-with-launch-of-rewoferm-rl-100-biosurfactant/ 2022-03-25T20:44:56+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/10/Evonik-for-website.png https://lifesciencesbc.ca/members/roche-provides-molecular-testing-solutions-to-identify-and-differentiate-sars-cov-2-omicron-variants-of-concern/ 2022-03-25T20:45:43+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/12/Roche-303x237-2.png https://lifesciencesbc.ca/members/lynparza-olaparib-reduced-risk-of-death-by-32-in-patients-with-germline-brca-mutated-her2-negative-high-risk-early-breast-cancer-in-phase-3-olympia-trial/ 2022-03-25T20:46:14+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Merck%20Canada%20Inc.jpg https://lifesciencesbc.ca/members/nimbus-synergies-leads-20-million-strategic-investment-in-clarius-mobile-health-to-accelerate-growth/ 2022-03-25T20:46:42+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/Nimbus-Synergies.jpg https://lifesciencesbc.ca/members/svb-honored-by-foreign-policy-association-for-corporate-social-responsibility/ 2022-03-25T20:47:08+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/04/Silicon-Valley-Bank.jpg https://lifesciencesbc.ca/members/pfizer-completes-acquisition-of-arena-pharmaceuticals/ 2022-03-25T20:50:03+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Pfizer%20Canada%20Inc..jpg https://lifesciencesbc.ca/members/breast-ct-authority-and-head-of-clinical-trials-joins-izotropic/ 2022-03-25T20:51:06+00:00 https://lifesciencesbc.ca/wp-content/uploads/2022/03/izotropic-corporation-2.png https://lifesciencesbc.ca/members/sanofi-announces-e300-million-collaboration-with-blackstone-life-sciences-to-advance-an-innovative-treatment-for-multiple-myeloma/ 2022-03-25T20:51:46+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Sanofi.jpg https://lifesciencesbc.ca/members/nervgen-pharma-receives-approval-from-safety-review-committee-to-proceed-to-second-cohort-in-multiple-ascending-dose-portion-of-phase-1-clinical-trial-of-nvg-291/ 2022-03-25T20:52:44+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/NervGen%20Pharma.jpg https://lifesciencesbc.ca/members/merck-announces-keylynk-010-trial-evaluating-keytruda-pembrolizumab-in-combination-with-lynparza-olaparib-in-patients-with-metastatic-castration-resistant-prostate-cancer-to-stop-for-f/ 2022-03-25T20:53:07+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Merck%20Canada%20Inc.jpg https://lifesciencesbc.ca/members/meeting-unprecedented-demand-from-the-telecommunications-industry/ 2022-03-25T20:53:56+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/National%20Research%20Council%20Canada.jpg https://lifesciencesbc.ca/members/numinus-wellness-numi-t-gets-health-canada-approval-for-ayahuasca/ 2022-03-25T20:54:24+00:00 https://lifesciencesbc.ca/wp-content/uploads/2022/01/numinus.jpg https://lifesciencesbc.ca/members/numinus-adds-ayahuasca-san-pedro-to-federal-license-for-psychedelic-research/ 2022-03-25T20:54:55+00:00 https://lifesciencesbc.ca/wp-content/uploads/2022/01/numinus.jpg https://lifesciencesbc.ca/members/new-paper-from-the-de-boer-lab-develops-oracle-to-predict-evolution-of-regulatory-dna/ 2022-03-25T20:55:40+00:00 https://lifesciencesbc.ca/wp-content/uploads/2022/03/Untitled-design-49.png https://lifesciencesbc.ca/members/essa-pharma-to-present-preclinical-data-for-its-first-generation-of-androgen-receptor-n-terminal-domain-degraders-at-the-2022-american-association-for-cancer-research-aacr-annual-meeting/ 2022-03-25T20:56:07+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/ESSA-1.jpg https://lifesciencesbc.ca/members/biotalent-canada-named-as-a-best-workplace-for-women-for-2022/ 2022-03-25T20:56:54+00:00 https://lifesciencesbc.ca/members/fusion-genomics-onetest-selected-for-pilot-pandemic-surveillance-study-at-toronto-pearson-international-airport/ 2022-03-25T20:57:22+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/FUSION%20GENOMICS.jpg https://lifesciencesbc.ca/members/construction-begins-for-new-st-pauls-hospital/ 2022-03-25T20:57:49+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/07/st-paul.jpg https://lifesciencesbc.ca/members/sanofi-recognized-by-sp-as-one-of-the-most-sustainability-committed-companies/ 2022-03-25T20:58:16+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/03/Sanofi.jpg